Download:
pdf |
pdfAttachment I. HIV/AIDS Surveillance Report
Reports of cases of AIDS, HIV infection, and HIV/AIDS
1
The HIV/AIDS Surveillance Report is published annually by the Division of HIV/AIDS Prevention–Surveillance
and Epidemiology, National Center for HIV, STD, and TB Prevention, Coordinating Center for Infectious Diseases,
Centers for Disease Control and Prevention, Atlanta, Georgia.
All data are provisional.
The HIV/AIDS Surveillance Report is not copyrighted and may be used and copied without permission. Citation of
the source is, however, appreciated.
Suggested citation
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Vol. 16. Atlanta: US Department
of Health and Human Services, Centers for Disease Control and Prevention; 2005:[inclusive page numbers]. Also
available at: http://www.cdc.gov/hiv/stats/hasrlink.htm.
Centers for Disease Control and Prevention ............................................................. Julie Louise Gerberding, M.D., M.P.H.
Director
Coordinating Center for Infectious Diseases ............................................................................................ Mitch Cohen, M.D.
Director
National Center for HIV, STD, and TB Prevention ........................................................... Ronald O. Valdiserri, M.D., M.P.H.
Acting Director
Division of HIV/AIDS Prevention—Surveillance and Epidemiology ................................ Robert S. Janssen, M.D.
Director
HIV Incidence and Case Surveillance Branch ........................................ Matthew T. McKenna, M.D., M.P.H.
Chief
Reporting, Analysis, and Evaluation Team ................................................................. Kate Glynn, D.V.M.
Team Supervisor
Research and Dissemination Team .................................................... Michael Campsmith, D.D.S., M.P.H.
Team Supervisor
Statistics and Data Management Branch .................................................................... Timothy A. Green, Ph.D.
Chief
Single copies: CDC National Prevention Information Network, P.O. Box 6003, Rockville, MD 20849-6003
Telephone: 1-800-458-5231 or 1-301-562-1098
Request to be added to mailing list: CDC, MASO/MSB, Mail Stop F-07, 4770 Buford Highway, Chamblee, GA 30341-3717
On the Web: http://www.cdc.gov, Select Publications, Software & Products
Confidential information, referrals, and educational material on HIV infection and AIDS:
CDC National AIDS Hotline, 1-800-342-2437, 1-800-344-7432 (Spanish), 1-800-243-7889 (TTY, deaf access)
Acknowledgments:
Publication of this report would not have been possible without the contributions of the State and Territorial Health
Departments and the HIV/AIDS Surveillance Programs which provided surveillance data to the Centers for Disease
Control and Prevention.
This report was prepared by the following staff and contractors of the Division of HIV/AIDS Prevention, National Center
for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention: Janet Brzuskiewicz, Michael Campsmith,
Robert Frey, Kate Glynn, Xiaohong Hu, Denise Hughes, Lisa M. Lee, Jianmin Li, Katrina McGhee, Matthew McKenna,
Anna Satcher, and Lynne Stockton.
The HIV/AIDS design element on the cover is used with the permission of the American Red Cross.
Federal Recycling Program
2
Printed on recycled paper
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Contents
Commentary...................................................................................................................................... 5
Section 1 Cases of HIV/AIDS and AIDS
Table 1.
Estimated numbers of cases of HIV/AIDS, by year of diagnosis and selected
characteristics of persons, 2001–2004—35 areas with confidential name-based
HIV infection reporting ................................................................................................................. 10
Table 2.
Estimated distribution of persons with and persons without a diagnosis of AIDS
within 12 months of diagnosis of HIV infection, by selected characteristics,
2003—35 areas with confidential name-based HIV infection reporting ........................................11
Table 3.
Estimated numbers of AIDS cases, by year of diagnosis and selected
characteristics of persons, 2000–2004—United States ................................................................. 12
Table 4.
Estimated numbers of AIDS cases in children <13 years of age, by year of
diagnosis and transmission category, 2000–2004—United States ................................................. 13
Figure 1. Estimated numbers of AIDS cases in children <13 years of age, by year of
diagnosis, 1992–2004—United States ........................................................................................... 13
Table 5a. Estimated numbers of cases and rates (per 100,000 population) of AIDS, by
race/ethnicity, age category, and sex, 2004—50 states and the District of Columbia ................... 14
Table 5b. Estimated numbers of cases and rates (per 100,000 population) of HIV/AIDS,
by race/ethnicity, age category, and sex, 2004—33 states with confidential
name-based HIV infection reporting ............................................................................................. 14
Table 6.
Estimated numbers of AIDS cases in adult and adolescent Hispanics,
by transmission category and place of birth, 2004—United States ............................................... 15
Section 2 Deaths
Table 7.
Estimated numbers of deaths of persons with AIDS, by year of death and
selected characteristics, 2000–2004—United States .................................................................... 16
Section 3 Persons living with HIV/AIDS, AIDS, or HIV infection
Table 8.
Estimated numbers of persons living with HIV/AIDS, by year and selected
characteristics, 2001–2004—35 areas with confidential name-based
HIV infection reporting ................................................................................................................. 17
Table 9.
Estimated numbers of persons living with HIV/AIDS at the end of 2004,
by race/ethnicity, sex, and transmission category—35 areas with confidential
name-based HIV infection reporting ............................................................................................. 18
Map 1.
Estimated rates for adults and adolescents living with HIV infection (not AIDS)
or with AIDS (per 100,000 population), 2004—United States ...................................................... 19
Map 2.
Estimated rates for children <13 years of age living with HIV infection (not AIDS)
or with AIDS (per 100,000 population), 2004—United States ...................................................... 19
Table 10. Estimated numbers of persons living with AIDS, by year and selected characteristics,
2000–2004—United States ........................................................................................................... 20
Table 11. Estimated numbers of persons living with AIDS at the end of 2004, by race/ethnicity,
sex, and transmission category—United States ............................................................................ 21
Table 12. Estimated numbers of persons living with HIV infection (not AIDS) or with AIDS
at the end of 2004, by area of residence and age category—United States ................................. 22
Reports of cases of AIDS, HIV infection, and HIV/AIDS
3
Section 4 Survival after AIDS diagnosis
Table 13. Proportion of persons surviving for more than 12, 24, and 36 months after an AIDS
diagnosis in 2000, by selected characteristics—United States ...................................................... 24
Figure 2. Proportion of persons surviving, by months after AIDS diagnosis during 1996–2003
and by year of diagnosis—United States ...................................................................................... 25
Figure 3. Proportion of persons surviving, by months after AIDS diagnosis during
1996–2003 and by age group—United States ............................................................................... 25
Figure 4. Proportion of persons surviving, by months after AIDS diagnosis during
1996–2003 and by race/ethnicity—United States ......................................................................... 26
Section 5 Reports of cases of AIDS, HIV infection, and HIV/AIDS
Table 14. Reported AIDS cases and annual rates (per 100,000 population), by area of
residence and age category, cumulative through 2004—United States ........................................ 27
Table 15. Reported AIDS cases and annual rates (per 100,000 population), by metropolitan
area of residence and age category, cumulative through 2004—United States ............................ 29
Table 16. Reported cases of HIV infection (not AIDS), by area of residence and age
category, cumulative through 2004—42 areas with confidential name-based
HIV infection reporting ................................................................................................................. 31
Table 17. Reported AIDS cases, by age category, transmission category, and sex, cumulative
through 2004—United States ........................................................................................................ 32
Table 18. Reported cases of HIV infection (not AIDS), by age category, transmission
category, and sex, cumulative through 2004—42 areas with confidential name-based
HIV infection reporting ................................................................................................................. 33
Table 19. Reported AIDS cases for male adults and adolescents, by transmission category
and race/ethnicity, cumulative through 2004—United States ........................................................ 34
Table 20. Reported cases of HIV infection (not AIDS) for male adults and adolescents, by
transmission category and race/ethnicity, cumulative through 2004—42 areas with
confidential name-based HIV infection reporting ......................................................................... 35
Table 21. Reported AIDS cases for female adults and adolescents, by transmission category
and race/ethnicity, cumulative through 2004—United States ........................................................ 36
Table 22. Reported cases of HIV infection (not AIDS) for female adults and adolescents, by
transmission category and race/ethnicity, cumulative through 2004—42 areas with
confidential name-based HIV infection reporting ......................................................................... 37
Table 23. Reported cases of HIV/AIDS in infants born to HIV-infected mothers, by year of
report and selected characteristics, 1994–2004—25 states with confidential
name-based HIV infection reporting ............................................................................................. 38
Technical Notes ............................................................................................................................. 39
Web addresses for state HIV Infection and AIDS Surveillance Reports ................................. 46
4
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Commentary
To better monitor the patterns of HIV diagnoses,
all states have implemented HIV surveillance. This
report presents estimated numbers of cases of HIV/
AIDS from the 35 areas (33 states, Guam, and the
U.S. Virgin Islands) with integrated HIV and AIDS
surveillance since at least 2000. Two of these areas
began integrated surveillance in 2000: Guam and New
York. New York is the state with the highest reported
percentage (18%) of cumulative national AIDS cases,
and inclusion of their integrated data resulted in large
numeric increases in the estimated number of HIV/
AIDS cases compared to previous HIV/AIDS
surveillance reports. From 2001 through 2004, the
total number of new cases of HIV/AIDS in the 35
areas decreased slightly; however, HIV/AIDS
prevalence (i.e., the number of persons living with
HIV/AIDS) increased during this time: at the end of
2004, an estimated 462,792 persons in the 35 areas
were diagnosed and living with HIV/AIDS. According to the number of reported AIDS cases, these 35
areas represent approximately 61% of the epidemic
in the United States. The map on the cover depicts
the estimated number of cases of HIV/AIDS in
2004, by area of residence at diagnosis, for persons
residing in the 33 states with integrated HIV and
AIDS surveillance.
Surveillance data on HIV infections provide a
more complete picture of the epidemic and the need
for prevention and care services than does the picture
provided by AIDS data alone. However, the number
of new HIV diagnoses does not necessarily reflect
trends in HIV incidence (i.e., new infections) because
some newly diagnosed persons were infected
recently while others were infected some time in the
past. One method for estimating HIV incidence is to
apply the serologic testing algorithm for recent HIV
seroconversion (STARHS) to the serum specimens
from which new HIV diagnoses were made. A total
of 34 areas are using this method to estimate population-based HIV incidence: 5 areas were funded in FY
2002 to pilot this method, 19 areas were funded in FY
2003, another 9 areas were funded in FY 2004 and
one additional area was funded in FY 2005. The
monitoring of HIV incidence will be critical in evaluating progress toward CDC’s HIV Prevention
Strategic Plan goal of reducing the number of new
HIV infections in the United States from 40,000 to
20,000 per year, to allocate resources and evaluate
prevention program effectiveness.
In 2002, CDC initiated the Interstate Duplication
Evaluation Project (IDEP), a formal evaluation
comparing HIV/AIDS records in the national database across states in order to identify potential
duplicate cases. Current IDEP de-duplication efforts
were completed in December 2004, and approximately 40,000 HIV/AIDS cases were found to be
duplicates (representing less than 5% of almost 1
million cases that have been reported to CDC over
the course of the epidemic); these duplicate cases
have been removed from the national surveillance
database and from individual state surveillance
databases. As a result of this correction there may be
minor reductions in reported cases displayed in this
surveillance report compared to the previous HIV/
AIDS surveillance report.
The 2004 HIV/AIDS Surveillance Report
presents data on cases of HIV/AIDS. For analyses
of HIV/AIDS data, we used data from 35 areas (i.e.,
33 states, Guam, and the U.S. Virgin Islands) with
mature HIV reporting systems (i.e., HIV reporting at
least since 2000) to allow for stabilization of data
collection and for adjustment of the data in order to
monitor trends. Tables 1, 2, 8, and 9 summarize cases
and prevalence of HIV/AIDS. For analyses of AIDS
cases, we used data from the 50 states, the District of
Columbia, U.S. dependencies, possessions, and
associated nations.
This report is organized in 5 sections: (1) cases of
HIV/AIDS and AIDS, (2) deaths of persons with
AIDS, (3) persons living with HIV/AIDS, AIDS, or
HIV infection (not AIDS), (4) length of survival after
AIDS diagnosis, and (5) reports of cases of AIDS,
HIV infection (not AIDS), and HIV/AIDS. In
Sections 1–3, we present point estimates of case
counts that have been adjusted for reporting delays
and for redistribution of cases in persons initially
reported without an identified risk factor. CDC
routinely adjusts data for the presentation of trends in
the epidemic. Data to estimate the number of cases
of HIV/AIDS or AIDS; the number of persons living
with HIV/AIDS, AIDS, or HIV infection (not AIDS);
and the number of deaths among persons with AIDS
have been statistically adjusted to correct for delays
in the reporting of cases and deaths. To assess trends
in cases, deaths, or prevalence, it is preferable to use
adjusted data, presented by year of diagnosis instead
of year of report, to eliminate artifacts of reporting in
the surveillance system. Therefore, for trends, the
Reports of cases of AIDS, HIV infection, and HIV/AIDS
5
reader is encouraged to use the tables in Sections 1–3
that present trends by year of diagnosis, year of
death, or year-end prevalence. Section 4 presents
estimates of survival for persons whose AIDS
diagnosis was made during 2000 (Table 13) and for
persons whose diagnosis was made during 1996–
2003 (Figures 2–4). Proportions of persons who
survived for various lengths of time after diagnosis
are presented by year of diagnosis, age group, race/
ethnicity, and HIV transmission category. Finally,
Section 5 presents reports of cases of HIV infection
(not AIDS) and cases of AIDS reported through
2004. The areas included in tabulations of reported
cases of HIV infection (not AIDS) are based on the
date that confidential name-based HIV infection
reporting was implemented. For Tables 16, 18, 20,
and 22, we used data from 42 areas to describe
reports of HIV infection. These data have not been
adjusted for delays in reporting and are presented by
year of report to CDC. Tables that present cases by
year of report represent the most up-to-date information reported to CDC; however, cases by year of
report do not represent incident cases, the most
recent diagnoses, trends, or deaths.
Highlights of Analyses
Cases of HIV/AIDS and cases of AIDS
Cases of HIV/AIDS
The estimated number of HIV/AIDS cases in
the 35 areas with confidential name-based HIV
infection reporting decreased year to year from 2001
through 2003 and then increased approximately 1%
from the end of 2003 (38,188) through the end of
2004 (38,730).
• Age group: From 2001 through 2004, the
estimated number of HIV/AIDS cases decreased
among children less than 13 years of age and in
the following age groups: 13–14, 30–34, 35–39,
40–44, and 45–49. The estimated number of
HIV/AIDS cases remained stable in the age
group 25–29 years, and increased in the following
age groups: 15–19, 20–24, 50–54, 55–59, 60–64,
and 65 years and older. The largest number of
HIV/AIDS cases occurred among persons age
35–39 years and accounted for 17% of all HIV/
AIDS cases diagnosed in 2004.
• Race/ethnicity: From 2001 through 2004, the
estimated number of HIV/AIDS cases increased
among whites, Asians/Pacific Islanders, and
American Indians/Alaska Natives, and decreased
6
among blacks and Hispanics. Blacks accounted
for 50% of all HIV/AIDS cases diagnosed
in 2004.
• Sex: From 2001 through 2004, the estimated
number of HIV/AIDS cases decreased
approximately 2% among males and 15% among
females. In 2004, males accounted for 73% of all
HIV/AIDS cases among adults and adolescents.
• Transmission category: From 2001 through
2004, the estimated number of HIV/AIDS cases
increased among men who have sex with men
(MSM). The estimated number of HIV/AIDS
cases decreased among injection drug users
(IDUs), MSM who were also IDUs, heterosexual
adults and adolescents, and among children.
MSM (47%) and persons exposed through
heterosexual contact (33%) accounted for 80%
of all HIV/AIDS cases diagnosed in 2004.
Of all HIV infections diagnosed in 2003, 39% progressed to AIDS within 12 months after HIV infection was diagnosed. AIDS was diagnosed within 12
months after the diagnosis of HIV infection for a
larger proportion of persons aged 35 years and older,
IDUs, and persons exposed through heterosexual
contact (Table 2).
Cases of AIDS
During 2000–2001, decreases in annual AIDS
cases began to level; however, after 2001, the
estimated number of AIDS cases increased each
year (Table 3). In 2004, the estimated rate of AIDS
cases in the United States was 14.1 per 100,000
population (Table 5a).
• Age group: From 2000 through 2004, the
estimated number of AIDS cases decreased 61%
among children less than 13 years of age, 11% in
the age group 30–34, and 10% in the age group
35–39 years, and remained stable in the age
group 13–14 years (Table 3). The estimated
number of AIDS cases increased in the following
age groups: 15–19, 20–24, 25–29, 40–44, 45–49,
50–54, 55–59, 60–64, and 65 years and older.
The largest number of AIDS cases occurred
among persons age 40–44 years and accounted
for 21% of all AIDS cases diagnosed in 2004.
• Race/ethnicity: From 2000 through 2004, the
estimated number of AIDS cases increased
among all racial and ethnic groups (Table 3). In
2004, rates of AIDS cases were 56.4 per 100,000
in the black population, 18.6 per 100,000 in the
Reports of cases of AIDS,
Commentary
HIV infection, and HIV/AIDS
•
•
•
Hispanic population, 7.9 per 100,000 in the
American Indian/Alaska Native population,
6.0 per 100,000 in the white population, and
3.7 per 100,000 in the Asian/Pacific Islander
population (Table 5a).
Sex: From 2000 through 2004, the estimated
number of AIDS cases increased 10% among
females and 7% among males. Males accounted
for 73% of all AIDS cases diagnosed in 2004
among adults and adolescents in the United
States (Table 3). Rates of AIDS cases in 2004
were 25.6 per 100,000 among males and 9.0 per
100,000 among females (Table 5a).
Transmission category: From 2000 through
2004, the estimated number of AIDS cases
decreased among IDUs and among MSM who
were also IDUs (Table 3). From 2000 through
2004, the estimated number of AIDS cases
increased among MSM. Among persons exposed
through heterosexual contact, the estimated
number of AIDS cases increased each year from
2000 through 2004.
Region: From 2000 through 2004, the estimated
number of AIDS cases increased 25% in the
South and 13% in the Midwest, and decreased
8% in the Northeast, 6% in the West, and 15% in
the U.S. dependencies, possessions, and associated nations.
Deaths
The estimated number of deaths among persons
with AIDS decreased 8% from 2000 through 2004
(Table 7).
• Age group: From 2000 through 2004, the
estimated number of deaths decreased among
children less than 13 years of age and in the
following age groups: 15–19, 25–29, 30–34, 35–
39, 40–44, and 45–49. The estimated number of
deaths increased in the age groups 13–14, 20–24,
50–54, 55–59, 60–64, and 65 years and older.
• Race/ethnicity: From 2000 through 2004, the
estimated number of deaths among persons with
AIDS decreased among whites, blacks, and
Asians/Pacific Islanders and increased among
Hispanics and American Indians/Alaska Natives.
• Sex and transmission category: From 2000
through 2004, among males, the estimated
number of deaths of MSM and IDUs decreased.
Among females, the estimated number of deaths
of IDUs decreased. The estimated number of
deaths increased from 2000 through 2004 among
•
adults and adolescents of both sexes exposed
through heterosexual contact.
Region: The estimated number of deaths in 2004
compared with 2003 decreased in the Northeast
and the Midwest; remained stable in the West
and increased in the South, and U.S. dependencies, possessions, and associated nations.
Persons living with HIV/AIDS, HIV
infection (not AIDS), or AIDS
Persons living with HIV/AIDS
The estimated number of persons living with
HIV/AIDS has increased steadily in the 35 areas
with confidential name-based HIV infection reporting
(Table 8). At the end of 2004, an estimated 462,792
persons were living with HIV/AIDS in the 35 areas
with confidential name-based HIV infection reporting
since 2000:
• By age group, the most cases (22%) were in the
age group 40–44 years.
• By race/ethnicity, 48% were black, 34% white,
17% Hispanic, and less than 1% each were
American Indian/Alaska Native and Asian/
Pacific Islander.
• By sex, 73% of adults and adolescents living with
HIV/AIDS were male.
• Of the estimated 332,578 male adults and adolescents living with HIV/AIDS, 60% were MSM,
19% were IDUs, 13% had been exposed through
heterosexual contact, and 7% were MSM who
also were IDUs. Of the estimated 123,405
female adults and adolescents living with HIV/
AIDS, 71% had been exposed through heterosexual contact, and 27% had been exposed
through injection drug use. Of the estimated 6,804
children living with HIV/AIDS, 90% had been
exposed perinatally.
Prevalence rates of HIV infection (not AIDS)
In the 35 areas with confidential name-based
HIV infection reporting, the prevalence rate of HIV
infection (not AIDS) among adults and adolescents
was estimated at 136.7 per 100,000 at the end of
2004 (Map 1). The rate for adults and adolescents
living with HIV infection (not AIDS) ranged from an
estimated 15.0 per 100,000 (North Dakota) to an
estimated 281.7 per 100,000 (U.S. Virgin Islands).
The prevalence rate of HIV infection (not AIDS)
among children residing in the 35 areas was an
estimated 7.9 per 100,000 at the end of 2004 (Map 2).
Reports of cases of AIDS,
Commentary
HIV infection, and HIV/AIDS
7
The rate for children living with HIV infection (not
AIDS) ranged from an estimated zero per 100,000 in
New Mexico, North Dakota, and Guam, to an
estimated 32.3 per 100,000 in New York.
Persons living with AIDS
AIDS prevalence has also increased steadily
since 2000 (Table 10). At the end of 2004, an estimated 415,193 persons in the United States were
living with AIDS:
• By age group, the most cases (23%) were in the
age group 40–44 years.
• By race/ethnicity, 43% were black, 35% white,
20% Hispanic, 1% Asian/Pacific Islander and
less than 1% American Indian/Alaska Native.
• By sex, 77% of adults and adolescents living with
AIDS were male.
• By region, 39% resided in the South, 29% in the
Northeast, 19% in the West, 10% in the Midwest,
and 3% in the U.S. dependencies, possessions,
and associated nations.
• Of the estimated 317,698 male adults and adolescents living with AIDS, 58% were MSM, 21%
were IDUs, 11% had been exposed through
heterosexual contact, and 8% were MSM who
were also IDUs. Of the estimated 93,566 female
adults and adolescents living with AIDS, 64%
had been exposed through heterosexual contact,
and 34% had been exposed through injection
drug use.
AIDS prevalence rates
In the United States, the prevalence rate of AIDS
among adults and adolescents was estimated at 168.8
per 100,000 at the end of 2004 (Map 1). The rate for
adults and adolescents living with AIDS ranged from
an estimated 4 per 100,000 (U.S. Pacific Islands) to
an estimated 1,906 per 100,000 (District of Columbia). The prevalence rate of AIDS among children in
the United States was estimated at 3.2 per 100,000 at
the end of 2004 (Map 2). The rate for children living
with AIDS ranged from an estimated zero per
100,000 in Guam, Idaho, Montana, Utah, and the U.S.
Pacific Islands to an estimated 52.8 per 100,000 in the
District of Columbia.
Survival after AIDS diagnosis
Table 13 is limited to data on AIDS cases
diagnosed in 2000 in order to describe the survival
of persons whose diagnosis was made relatively
8
recently, but far enough in the past to permit a
meaningful measure of survival. Figures 2, 3, and 4
illustrate the proportion of surviving persons among
persons whose diagnoses were made over a longer
period, 1996 through 2003.
•
•
•
•
Survival (the estimated proportion of persons
surviving a given length of time after diagnosis)
increased with the year of diagnosis for diagnoses
made during 1996–1999. Year-to-year differences
were small during 1999–2003 (Figure 2).
Survival decreased as age at diagnosis increased
among persons at least 35 years old at diagnosis
and in comparison with persons younger than 35.
Survival was similar for the age groups 13–24
and 25–34. Survival was greatest among children
less than 13 years of age at diagnosis (Figure 3).
Survival was greatest among MSM and among
children with perinatally acquired HIV infection
(Table 13). Survival was intermediate among men
and women who had heterosexual contact with
someone known to be HIV infected or at high
risk for HIV infection, as well as among MSM
who also were IDUs. Survival was lowest among
men and women who were IDUs.
Survival, particularly at more than 48 months
after diagnosis, was greater among Asians/
Pacific Islanders, whites, and Hispanics, than
among blacks (Figure 4). Results were unstable
or inconsistent for American Indians/Alaska
Natives because the numbers of persons in this
racial/ethnic category were small.
Reports of Cases of AIDS, HIV infection
(not AIDS), and HIV/AIDS
Tables 14–23 describe reports of cases of AIDS,
HIV infection (not AIDS), and of HIV/AIDS. Tables
16, 18, 20, and 22 are based on reports of cases of
HIV infection (not AIDS) through 2004 from the 42
areas that had implemented name-based HIV infection reporting. Note that not all cases of HIV infection (not AIDS) or AIDS reported in 2004 reflected
new diagnoses; rather, the reported cases include
cases diagnosed during earlier years.
Reports of cases of HIV infection (not AIDS)
Through 2004, a total of 229,411 persons were
reported as having HIV infection (not AIDS) in the
42 areas with confidential name-based HIV infection
reporting (Table 16). Five states (New York, Florida,
Reports of cases of AIDS,
Commentary
HIV infection, and HIV/AIDS
Texas, New Jersey, and North Carolina) reported
121,787 (53%) of the 229,411 cumulative cases of
HIV infection (not AIDS) reported to CDC. In 2004,
3 states (New York, Florida, and Texas) reported
15,283 (46%) of the 33,563 cases of HIV infection
(not AIDS).
• By sex, in 2004, 70% of the 33,132 reported
cases of HIV infection (not AIDS) among adults
and adolescents were in males, and 30% were in
females (Table 18).
• In 2004, 431 cases of HIV infection (not AIDS)
in children were reported.
Reports of AIDS cases
Through 2004, a total of 918,286 persons had
been reported as having AIDS in the United States,
dependencies, possessions, and associated nations
(Table 14). Three states (California, Florida, and
New York) reported 43% of the cumulative AIDS
cases, and 41% of AIDS cases reported to CDC in
2004. In the United States, the rate of reported AIDS
cases in 2004 was 15.0 per 100,000 population. The
rate of reported AIDS cases ranged from zero per
100,000 (U.S. Pacific Islands) to 179.2 per 100,000
(District of Columbia).
• By sex, in 2004, males accounted for 73% and
females for 27% of 44,615 reported AIDS cases
among adults and adolescents (Table 17).
• In 2004, 122 AIDS cases in children were
reported.
Additional Resources
The following were prepared by using HIV/AIDS
surveillance data:
• Selected MMWR articles at www.cdc.gov/hiv/
pubs/mmwr.htm
• Public-use slides at www.cdc.gov/hiv/
graphics.htm
•
•
Other surveillance reports at www.cdc.gov/hiv/
stats/hasrlink.htm
Public-use version of the AIDS surveillance data
set (AIDS Public Information Data Set [APIDS])
at www.cdc.gov/hiv/software/apids.htm
Suggested Readings
CDC. Advancing HIV prevention: new strategies for
a changing epidemic—United States, 2003.
MMWR 2003;52:329-332.
CDC. Diagnosis and reporting of HIV and AIDS in
25 states—United States, 1994–2000. MMWR
2002;51:595-598.
CDC. Guidelines for national HIV case surveillance,
including monitoring for HIV infection and AIDS.
MMWR 1999;48(No. RR-13):1-31.
CDC. HIV Prevention Strategic Plan Through
2005. Atlanta: U.S. Department of Health and
Human Services, CDC; 2001. Available at http://
www.cdc.gov/hiv/partners/psp.htm.
CDC. Increases in HIV diagnoses—29 states, 1999–
2002. MMWR 2003;52:1145-1148.
CDC. Update: the AIDS epidemic in the United
States, 2001. MMWR 2002;51:592-595.
Janssen RS, Satten GA, Stramer SL, et al. New
testing strategy to detect early HIV-1 infection
for use in incidence estimates and for clinical and
prevention purposes. JAMA 1998;280:42-48.
Karon JM, Fleming PL, Steketee RW, De Cock KM.
HIV in the United States at the turn of the
century: an epidemic in transition. Am J Public
Health 2001;91:1060-1068.
Nakashima AK, Fleming PL. HIV/AIDS surveillance
in the United States, 1981–2001. J Acquir
Immune Defic Syndr 2003;32:68-85.
CDC. Diagnoses of HIV/AIDS—32 states, 2000–
2003. MMWR 2004;53:1106-1110.
Reports of cases of AIDS,
Commentary
HIV infection, and HIV/AIDS
9
Table 1. Estimated numbers of cases of HIV/AIDS, by year of diagnosis and selected characteristics of
persons, 2001–2004—35 areas with confidential name-based HIV infection reporting
Year of diagnosis
Cumulative
2001
2002
2003
2004
360
53
1,012
3,241
4,608
6,776
8,261
6,699
4,709
2,735
1,411
730
674
288
46
1,023
3,154
4,499
6,305
7,719
6,395
4,486
2,643
1,330
763
627
203
53
1,027
3,345
4,290
5,688
7,112
6,483
4,514
2,733
1,414
705
623
174
41
1,080
3,762
4,604
5,527
6,754
6,344
4,536
2,776
1,594
804
734
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
11,242
21,556
7,714
279
171
11,352
20,237
6,964
319
202
11,097
19,310
7,078
367
187
11,806
19,206
6,970
394
208
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Othera
Subtotal
16,625
5,171
1,525
5,095
214
28,630
16,852
4,379
1,431
4,843
183
27,689
16,804
4,177
1,398
4,720
179
27,279
18,203
3,828
1,372
4,581
161
28,143
Female adult or adolescent
Injection drug use
Heterosexual contact
Othera
Subtotal
2,877
9,192
211
12,280
2,408
8,709
187
11,303
2,252
8,248
205
10,706
2,134
8,102
174
10,410
Child (<13 yrs at diagnosis)
Perinatal
Otherb
Subtotal
306
54
360
245
44
288
186
18
204
145
32
177
41,207
39,222
38,139
38,685
Age at diagnosis (yrs)
< 13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
Subtotal for 33 states with confidential
name-based HIV infection reporting
Subtotal for U.S. dependencies, possessions,
and associated nations with confidential
name-based HIV infection reporting
Totalc
63
58
49
45
41,270
39,280
38,188
38,730
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
Data include persons with a diagnosis of HIV infection. This includes persons with a diagnosis of HIV infection only, a diagnosis of
HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama,
Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri,
Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota,
Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam and the U.S. Virgin Islands. Since July 1997, Florida has
had confidential name-based HIV infection reporting only for new diagnoses.
a
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
b
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
c
Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated
independently of the values for the subpopulations, the values in each column may not sum to the column total.
10
Reports of cases
HIV infection,
CasesofofAIDS,
HIV/AIDS
and AIDSand HIV/AIDS
Table 2. Estimated distribution of persons with and persons without a diagnosis of AIDS within 12
months of diagnosis of HIV infection, by selected characteristics, 2003—35 areas with
confidential name-based HIV infection reporting
AIDS diagnoses
≥12 Months
after diagnosis
of HIV infection
<12 Months
after diagnosis
of HIV infection
Total
No.
(%)a
No.
(%)a
No.
(%)a
163
37
880
2,649
3,050
3,547
4,077
3,710
2,421
1,404
733
327
258
80
70
86
79
71
62
57
57
54
51
52
46
41
40
16
145
691
1,232
2,134
3,024
2,761
2,091
1,327
679
377
365
20
30
14
21
29
38
43
43
46
49
48
54
59
203
53
1,026
3,340
4,283
5,681
7,101
6,471
4,513
2,731
1,412
705
623
100
100
100
100
100
100
100
100
100
100
100
100
100
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
6,856
11,682
4,279
229
120
62
61
61
62
65
4,234
7,603
2,785
139
66
38
39
39
38
35
11,090
19,285
7,063
367
187
100
100
100
100
100
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Otherb
Subtotal
10,428
2,224
828
2,586
75
16,140
62
53
59
55
42
59
6,354
1,948
569
2,125
104
11,101
38
47
41
45
58
41
16,782
4,172
1,397
4,710
179
27,241
100
100
100
100
100
100
Female adult or adolescent
Injection drug use
Heterosexual contact
Otherb
Subtotal
1,422
5,426
108
6,956
63
66
53
65
830
2,815
97
3,742
37
34
47
35
2,252
8,240
205
10,697
100
100
100
100
Child (<13 yrs at diagnosis)
Perinatal
Otherc
Subtotal
Totald
147
16
163
23,259
79
92
80
61
39
1
41
14,883
21
8
20
39
186
18
204
38,142
100
100
100
100
Age at diagnosis (yrs)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
Data include persons in whom AIDS has developed and persons whose first diagnosis of HIV infection and the diagnosis of AIDS
were made at the same time.
Data exclude 46 persons whose month of diagnosis of HIV infection is unknown.
Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama,
Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri,
Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota,
Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam and the U.S. Virgin Islands. Since July 1997, Florida has
had confidential name-based HIV infection reporting only for new diagnoses.
a
Percentages represent proportions of the total number of diagnoses of HIV/AIDS made during 2003 for the corresponding group (see
row entries). Because row totals were calculated independently of the values for the subpopulations, the values in each row may
not sum to the row total.
b
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
c
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
d
Includes 149 persons of unknown race or multiple races. Because column totals were calculated independently of the values for the
subpopulations, the values in each column may not sum to the column total.
Reports of cases
Casesofof
AIDS,
HIV/AIDS
HIV infection,
and AIDS
and HIV/AIDS
11
Table 3. Estimated numbers of AIDS cases, by year of diagnosis and selected characteristics of
persons, 2000–2004— United States
Year of diagnosis
Cumulative
through 2004 a
2000
2001
2002
2003
2004
124
60
291
1,329
3,432
6,497
8,930
7,530
5,200
3,007
1,528
833
752
115
79
274
1,343
3,239
6,258
8,649
7,502
5,401
3,199
1,567
820
759
109
71
312
1,467
3,279
6,010
8,716
7,825
5,656
3,436
1,718
930
738
69
58
301
1,664
3,276
6,003
8,763
8,291
6,102
3,672
1,854
929
848
48
60
326
1,788
3,576
5,786
8,031
8,747
6,245
3,932
2,079
996
901
9,443
959
4,936
34,164
114,642
195,404
208,199
161,964
99,644
54,869
29,553
16,119
14,410
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
11,378
19,510
7,957
350
175
11,052
19,473
7,974
381
169
11,604
19,934
7,907
440
186
11,657
20,685
8,632
478
189
12,013
20,965
8,672
488
193
375,155
379,278
177,164
7,317
3,084
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Otherb
Subtotal
15,374
7,036
2,102
4,162
300
28,974
15,510
6,447
2,056
4,440
290
28,743
16,442
6,247
1,982
4,771
288
29,730
17,139
6,213
1,996
4,967
263
30,578
17,691
5,968
1,920
5,149
298
31,024
441,380
176,162
64,833
59,939
14,085
756,399
Female adult or adolescent
Injection drug use
Heterosexual contact
Otherb
Subtotal
3,393
6,785
237
10,415
3,175
6,930
243
10,348
3,008
7,181
240
10,429
3,068
7,859
257
11,184
3,184
7,979
279
11,442
72,651
99,175
6,636
178,463
Child (<13 yrs at diagnosis)
Perinatal
Otherc
Subtotal
122
2
124
113
3
115
105
4
109
68
1
69
47
0
48
8,779
664
9,443
12,105
3,968
15,841
6,443
11,212
3,949
16,598
6,258
10,395
4,303
17,751
6,745
11,149
4,495
18,612
6,474
11,158
4,498
19,792
6,083
289,792
93,701
343,449
187,730
1,156
1,190
1,073
1,100
982
29,634
Age at diagnosis (yrs)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
Region of residence
Northeast
Midwest
South
West
U.S. dependencies, possessions, and
associated nations
Totald
39,513
39,206
40,267
41,831
42,514
944,306
39,513
39,206
40,267
41,831
42,514
944,306
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
a
Includes persons with a diagnosis of AIDS from the beginning of the epidemic through 2004.
b
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
c
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
d
Includes persons of unknown race or multiple races and persons of unknown sex. Cumulative total includes 2,308 persons of
unknown race or multiple races and 2 persons of unknown sex. Because column totals were calculated independently of the values
for the subpopulations, the values in each column may not sum to the column total.
12
Reports ofCases
casesof
of HIV/AIDS
AIDS, HIVand
infection,
AIDS and HIV/AIDS
Table 4. Estimated numbers of AIDS cases in children <13 years of age, by year of diagnosis and
transmission category, 2000–2004—United States
Year of diagnosis
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Transmission category
Hemophilia/coagulation disorder
Mother with the following risk factor
for, or documented, HIV infection
Injection drug use
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion recipient
Sex with HIV-infected person, risk factor not specified
Receipt of blood transfusion, blood components, or tissue
Has HIV infection, risk factor not specified
Receipt of blood transfusion, blood components, or tissue
Other/risk factor not reported or identified
Totalb
2000
2001
2002
2003
2004
Cumulative
through 2004 a
11
93
18
2
0
13
79
22
1
0
14
71
21
1
1
12
43
12
0
1
7
29
8
1
1
1,612
5,590
2,128
53
34
0
0
0
0
0
230
122
113
105
68
47
8,779
23
15
3
0
0
35
2
45
14
7
3
1
0
36
1
49
9
4
3
0
0
38
2
48
9
7
0
0
0
20
1
31
5
2
2
0
0
18
0
19
3,338
1,524
201
37
27
1,515
152
1,984
1
1
0
3
2
1
0
1
0
0
389
45
124
115
109
69
48
9,443
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
a
Includes children with a diagnosis of AIDS, from the beginning of the epidemic through 2004.
b
Includes children of unknown race or multiple races. Cumulative total includes 24 children of unknown race or multiple races.
Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
Figure 1. Estimated numbers of AIDS cases in children <13 years of age, by year of diagnosis,
1992–2004—United States
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays. The estimates do not include
adjustment for incomplete reporting.
Reports of cases
Cases
of of
AIDS,
HIV/AIDS
HIV infection,
and AIDS
and HIV/AIDS
13
Table 5a. Estimated numbers of cases and rates (per 100,000 population) of AIDS, by race/ethnicity,
age category, and sex, 2004—50 states and the District of Columbia
Adults or adolescents
Males
Race/ethnicity
No.
Females
Rate
No.
Total
Rate
Children (<13 yrs)
No.
Rate
No.
Rate
Total
No.
Rate
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
10,118
13,398
6,041
392
128
12.3
99.4
37.9
7.5
13.5
1,860
7,395
1,643
92
64
2.1
48.2
11.1
1.6
6.4
11,978
20,793
7,684
484
192
7.1
72.1
25.0
4.4
9.9
7
29
7
1
1
0.0
0.4
0.1
0.1
0.2
11,985
20,822
7,691
486
193
6.0
56.4
18.6
3.7
7.9
Totala
30,203
25.6
11,109
9.0
41,312
17.1
46
0.1
41,359
14.1
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays. The estimates do not include
adjustment for incomplete reporting.
Data exclude cases from the U.S. dependencies, possessions, and associated nations, as well as cases in persons whose state or
area of residence is unknown, because of the lack of census information by race and age categories for these areas.
a
Includes persons of unknown race or multiple races. Total includes 183 persons of unknown race or multiple races. Because column
totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 5b. Estimated numbers of cases and rates (per 100,000 population) of HIV/AIDS, by race/ethnicity,
age category, and sex, 2004—33 states with confidential name-based HIV infection reporting
Adults or adolescents
Males
Race/ethnicity
No.
Females
Rate
No.
Rate
Total
No.
Rate
Children (<13 yrs)
No.
Rate
Totala
No.
Rate
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
10,010
12,048
5,517
299
148
18.7
131.6
60.2
13.9
20.8
1,782
7,009
1,400
94
57
3.2
67.0
16.3
4.1
7.7
11,791
19,057
6,916
393
205
10.7
97.2
39.0
8.9
14.1
9
129
37
0
1
0.0
2.3
0.6
0.0
0.3
11,801
19,185
6,953
393
206
9.0
76.3
29.5
7.2
11.1
Totalb
28,117
37.6
10,391
13.2
38,508
25.1
177
0.5
38,685
20.7
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays. The estimates do not include
adjustment for incomplete reporting.
Data include persons with a diagnosis of HIV infection. This includes persons with a diagnosis of HIV infection only, a diagnosis of
HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 2000, the following 33 states have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama,
Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri,
Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota,
Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, and Wyoming. Since July 1997, Florida has had confidential name-based
HIV infection reporting only for new diagnoses.
a
Because row totals were calculated independently of values for the subpopulations, the value in each row may not sum to the
row total.
b
Includes persons of unknown race or multiple races. Total includes 146 persons of unknown race or multiple races. Because column
totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
14
Reports ofCases
cases of
of HIV/AIDS
AIDS, HIV and
infection,
AIDS and HIV/AIDS
Table 6. Estimated numbers of AIDS cases in adult and adolescent Hispanics, by transmission
category and place of birth, 2004—United States
Place of birth
United States
Transmission category
Central/South
America
No.
%
No.
%
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contact
Otherb
1,182
704
43
25
437
105
52
13
147
703
32
5
25
1
19
264
11
2
32
1
Totalc
2,769 100
836 100
Cuba
No.
Mexico
Puerto Rico
Totala
%
No.
%
No.
%
No.
%
121
26
59
13
860
162
60
11
313
617
20
39
3,642
2,095
42
24
9
47
1
5
23
0
48
354
18
3
25
1
66
588
11
4
37
1
352
2,478
96
4
29
1
204 100
1,443 100
1,595 100
8,663 100
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
a
Includes 269 persons whose place of birth is not among those listed and 1,548 persons whose place of birth is unknown. Because
row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.
b
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
c
Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum
to the column total.
Reports of cases
Cases
of AIDS,
of HIV/AIDS
HIV infection,
and AIDS
and HIV/AIDS
15
Table 7. Estimated numbers of deaths of persons with AIDS, by year of death and selected
characteristics, 2000–2004—United States
Year of death
Cumulative
through 2004a
2000
2001
2002
2003
2004
Age at death (yrs)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
52
8
41
167
710
1,993
3,346
3,523
3,081
1,966
1,007
593
652
46
4
44
215
635
1,744
3,292
3,835
3,121
2,152
1,141
655
728
32
11
39
167
595
1,555
3,108
3,726
3,364
2,396
1,228
621
702
28
7
43
175
569
1,373
2,969
3,800
3,432
2,524
1,403
726
801
18
16
32
184
505
1,157
2,404
3,378
3,016
2,314
1,343
701
730
5,094
266
1,055
8,808
44,516
96,357
116,206
100,633
67,842
39,936
22,452
12,946
13,004
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
5,325
8,605
3,025
95
66
5,194
9,011
3,195
100
81
5,210
8,974
3,117
91
84
5,091
8,950
3,537
81
73
4,316
7,978
3,228
82
91
229,220
201,045
93,163
3,272
1,578
5,955
4,070
1,324
1,389
195
12,933
6,068
4,074
1,366
1,528
166
13,202
6,016
4,062
1,323
1,513
167
13,080
5,990
4,116
1,322
1,634
160
13,222
5,450
3,308
1,180
1,548
113
11,599
256,053
109,070
39,467
24,268
9,843
438,701
Female adult or adolescent
Injection drug use
Heterosexual contact
Otherb
Subtotal
1,892
2,150
87
4,129
1,907
2,342
91
4,340
1,977
2,331
91
4,400
1,989
2,470
101
4,560
1,744
2,327
67
4,138
41,178
39,576
4,142
84,897
Child (<13 yrs at diagnosis)
Perinatal
Otherc
Subtotal
72
5
77
66
3
69
59
6
65
61
6
67
57
4
61
4,982
533
5,515
5,200
1,622
7,078
2,567
5,130
1,646
7,386
2,683
5,213
1,623
7,361
2,585
5,654
1,199
7,839
2,428
4,019
1,234
7,192
2,540
169,693
50,333
181,690
108,183
672
766
763
730
814
19,214
17,139
17,611
17,544
17,849
15,798
529,113
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Otherb
Subtotal
Region of residence
Northeast
Midwest
South
West
U.S. dependencies, possessions, and
associated nations
Total
d
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
a
Includes persons who died with AIDS, from the beginning of the epidemic through 2004.
b
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
c
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
d
Includes persons of unknown race or multiple races and persons of unknown sex. Cumulative total includes 836 persons of
unknown race or multiple races. Because column totals were calculated independently of the values for the subpopulations, the
values in each column may not sum to the column total.
16
Reports of cases of AIDS,
HIV infection, and HIV/AIDS
Deaths
Table 8. Estimated numbers of persons living with HIV/AIDS, by year and selected characteristics,
2001–2004—35 areas with confidential name-based HIV infection reporting
2001
2002
2003
2004
Age as of end of year (yrs)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
4,838
830
2,745
11,500
25,334
52,672
82,539
79,325
59,008
34,929
16,271
7,781
6,674
4,598
950
2,968
12,033
25,768
51,896
83,133
86,422
65,879
40,488
19,550
9,497
7,816
4,187
1,123
3,301
12,582
26,538
50,416
81,891
93,414
72,498
45,932
23,286
11,098
9,099
3,713
1,239
3,683
13,371
27,836
49,133
80,086
99,742
79,728
52,658
27,571
13,170
10,861
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
133,475
181,964
63,105
1,796
1,587
141,120
195,147
68,252
2,084
1,728
148,459
206,936
72,967
2,415
1,865
157,172
220,028
78,039
2,765
1,996
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Othera
Subtotal
159,937
57,287
21,643
34,386
3,445
276,698
172,502
58,959
22,201
37,986
3,524
295,172
184,778
60,113
22,688
41,291
3,602
312,472
199,085
61,799
23,337
44,655
3,702
332,578
Female adult or adolescent
Injection drug use
Heterosexual contact
Othera
Subtotal
30,977
68,173
2,077
101,227
32,003
74,925
2,236
109,164
32,742
81,007
2,383
116,133
33,621
87,262
2,523
123,405
Child (<13 yrs at diagnosis)
Perinatal
Otherb
Subtotal
5,810
706
6,515
5,954
703
6,657
6,057
698
6,755
6,100
704
6,804
Totalc
384,446
410,998
435,364
462,792
,,
,,
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
Data include persons with a diagnosis of HIV infection. This includes persons with a diagnosis of HIV only, a diagnosis of HIV
infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama,
Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri,
Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota,
Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam and the U.S. Virgin Islands. Since July 1997, Florida has
had confidential name-based HIV infection reporting only for new diagnoses.
a
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
b
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
c
Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated
independently of the values for the subpopulations, the values in each column may not sum to the column total.
Reports
Persons
ofliving
cases with
of AIDS,
HIV/AIDS,
HIV infection,
AIDS, orand
HIV
HIV/AIDS
infection
17
Table 9. Estimated numbers of persons living with HIV/AIDS at the end of 2004, by race/ethnicity, sex, and transmission
category—35 areas with confidential name-based HIV infection reporting
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contact
Otherb
Subtotal
White, not
Hispanic
No.
%
Black, not
Hispanic
No.
%
Hispanic
No.
%
Asian/Pacific
Islander
No.
%
American
Indian/Alaska
Native
No.
%
Totala
No.
%
101,119
12,750
76
10
63,112
33,237
46
24
31,412
14,990
54
26
1,415
267
66
12
879
218
61
15
199,085
61,799
60
19
10,667
6,260
1,580
132,376
8
5
1
100
9,030
29,458
1,617
136,454
7
22
1
100
3,237
8,109
411
58,159
6
14
1
100
74
334
50
2,141
3
16
2
100
191
146
18
1,452
13
10
1
100
23,337
44,655
3,702
332,578
7
13
1
100
Female adult or adolescent
Injection drug use
Heterosexual contact
Otherb
Subtotal
8,104
15,256
481
23,841
34
64
2
100
19,554
57,991
1,626
79,170
25
73
2
100
5,521
12,636
357
18,513
30
68
2
100
96
470
30
596
16
79
5
100
168
347
10
525
32
66
2
100
33,621
87,262
2,523
123,405
27
71
2
100
Child (<13 yrs at diagnosis)
Perinatal
Otherc
Subtotal
793
161
953
83
17
100
4,013
389
4,402
91
9
100
1,228
138
1,366
90
10
100
23
4
27
85
15
100
18
1
19
95
5
100
6,100
704
6,804
90
10
100
Totald
157,172
220,028
78,039
2,765
1,996
462,792
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case
counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor.
The estimates do not include adjustment for incomplete reporting.
Data include persons with a diagnosis of HIV infection. This includes persons with a diagnosis of HIV infection only, a diagnosis of HIV infection and a later
AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona,
Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico,
New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming,
Guam and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.
a
Includes 2,793 persons of unknown race or multiple races.
b
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
c
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
d
Includes 5 persons of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column
may not sum to the column total.
18
Persons
Reportsliving
of cases
withofHIV/AIDS,
AIDS, HIVAIDS,
infection,
or HIV
andinfection
HIV/AIDS
Reports
Persons
ofliving
cases with
of AIDS,
HIV/AIDS,
HIV infection,
AIDS, orand
HIVHIV/AIDS
infection
19
Table 10. Estimated numbers of persons living with AIDS, by year and selected characteristics,
2000–2004—United States
2000
2001
2002
2003
2004
Age as of end of year (yrs)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
2,843
513
1,212
3,732
14,081
40,392
72,320
71,600
53,835
31,610
14,859
7,230
5,950
2,611
640
1,355
3,846
13,338
38,347
73,246
77,379
60,650
37,146
17,683
8,496
7,036
2,353
718
1,569
4,045
13,036
36,636
72,596
83,415
67,393
43,019
21,159
10,256
8,300
2,034
759
1,789
4,479
13,170
35,058
70,827
89,732
74,451
48,934
25,376
11,988
9,880
1,695
776
2,043
4,942
13,721
33,669
68,389
95,874
81,636
56,336
30,033
14,228
11,850
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
119,420
132,090
63,894
2,612
1,099
125,279
142,552
68,673
2,893
1,187
131,672
153,512
73,463
3,242
1,288
138,238
165,246
78,557
3,638
1,404
145,935
178,233
84,001
4,045
1,506
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Othera
Subtotal
142,069
57,778
22,603
22,568
3,708
248,726
151,511
60,150
23,293
25,480
3,833
264,267
161,937
62,335
23,953
28,738
3,954
280,917
173,086
64,432
24,627
32,071
4,057
298,272
185,326
67,091
25,367
35,671
4,242
317,698
Female adult or adolescent
Injection drug use
Heterosexual contact
Othera
Subtotal
26,656
39,121
1,824
67,601
27,924
43,708
1,977
73,610
28,955
48,559
2,125
79,639
30,033
53,947
2,282
86,262
31,472
59,599
2,494
93,566
Child (<13 yrs at diagnosis)
Perinatal
Otherb
Subtotal
3,706
142
3,848
3,753
142
3,895
3,799
140
3,939
3,807
134
3,941
3,797
131
3,927
Region of residence
Northeast
Midwest
South
West
U.S. dependencies, possessions, and associated nations
96,201
31,825
118,784
64,221
9,146
102,283
34,128
127,996
67,797
9,570
107,464
36,808
138,386
71,957
9,881
112,960
40,104
149,159
76,003
10,251
120,099
43,368
161,759
79,547
10,419
Totalc
320,177
341,773
364,496
388,477
415,193
320,177 341,773 364,496 388,477 415,193
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in
persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting.
a
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
b
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
c
Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated
independently of the values for the subpopulations, the values in each column may not sum to the column total.
20
Persons
Reports
living
of cases
with HIV/AIDS,
of AIDS, HIV
AIDS,
infection,
or HIVand
infection
HIV/AIDS
Table 11. Estimated numbers of persons living with AIDS at the end of 2004, by race/ethnicity, sex, and transmission
category—United States
White, not
Hispanic
Black, not
Hispanic
Hispanic
No.
%
No.
No.
95,737
13,137
75
10
52,120
34,797
44
29
11,366
5,291
1,854
127,385
9
4
1
100
9,174
21,565
1,654
119,310
Female adult or adolescent
Injection drug use
Heterosexual contact
Otherb
Subtotal
7,147
10,313
529
17,990
40
57
3
100
Child (<13 yrs at diagnosis)
Perinatal
Otherc
Subtotal
508
51
559
91
9
100
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contact
Otherb
Subtotal
Totald
145,935
%
Asian/Pacific
Islander
American
Indian/Alaska
Native
Totala
%
No.
%
No.
%
33,717
18,472
52
28
2,445
314
72
9
645
190
56
17
185,326
67,091
58
21
8
18
1
100
4,361
8,204
619
65,373
7
13
1
100
162
387
76
3,384
5
11
2
100
195
96
17
1,141
17
8
1
100
25,367
35,671
4,242
317,698
8
11
1
100
18,184
36,791
1,474
56,449
32
65
3
100
5,802
11,561
416
17,780
33
65
2
100
102
491
51
644
16
76
8
100
136
203
11
350
39
58
3
100
31,472
59,599
2,494
93,566
34
64
3
100
2,435
39
2,474
98
2
100
809
39
848
95
5
100
16
1
17
93
7
100
14
0
14
99
1
100
3,797
131
3,927
97
3
100
178,233
84,001
4,045
1,506
No.
%
415,193
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case
counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor.
The estimates do not include adjustment for incomplete reporting.
a
Includes 1,472 persons of unknown race or multiple races.
b
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
c
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
d
Includes 2 person of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column
may not sum to the column total.
Reports
Persons
ofliving
cases with
of AIDS,
HIV/AIDS,
HIV infection,
AIDS, orand
HIV
HIV/AIDS
infection
21
Table 12. Estimated numbers of persons living with HIV infection (not AIDS) or with AIDS at the end of
2004, by area of residence and age category—United States
Living with HIV infection (not AIDS)a
Area of residence
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Floridab
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Subtotal
22
Adults or
adolescents
5,232
241
5,288
2,154
—
5,650
—
—
—
33,331
—
—
333
—
3,651
506
1,099
—
7,518
—
—
—
5,945
3,038
4,041
4,701
—
605
3,076
—
14,933
872
38,083
10,886
81
7,829
2,251
—
—
—
6,491
170
6,414
22,460
744
—
9,105
—
630
2,206
78
209,641
Children
<13 years old
26
1
45
9
—
14
—
—
—
268
—
—
1
—
24
3
7
—
103
—
—
—
62
21
34
34
—
6
13
—
263
0
1,046
71
0
55
16
—
—
—
55
2
68
307
9
—
49
—
5
17
1
2,634
Total
5,258
242
5,332
2,163
—
5,664
—
—
—
33,599
—
—
334
—
3,675
509
1,106
—
7,621
—
—
—
6,007
3,059
4,075
4,735
—
611
3,089
—
15,196
872
39,129
10,957
81
7,884
2,267
—
—
—
6,546
172
6,482
22,767
753
—
9,154
—
635
2,223
79
212,275
Living with AIDS
Adults or
adolescents
Children
<13 years old
3,338
299
4,063
2,027
56,855
3,738
6,447
1,628
8,993
44,829
14,190
1,267
277
15,355
3,713
746
1,145
2,345
7,440
498
12,980
8,221
5,677
2,049
3,061
5,011
175
635
2,644
532
17,310
1,158
69,860
7,225
65
6,689
1,940
2,536
15,207
1,155
6,525
109
5,742
29,816
1,121
230
7,871
5,131
657
1,931
101
402,561
Persons
Reports
living
of cases
with HIV/AIDS,
of AIDS, HIV
AIDS,
infection,
or HIVand
infection
HIV/AIDS
14
1
5
9
133
3
24
11
43
311
56
4
0
63
18
3
2
9
32
3
65
32
20
10
17
10
0
3
5
3
99
3
273
20
1
33
3
5
101
10
29
3
11
75
0
3
45
5
5
11
1
1,645
Total
3,352
300
4,068
2,036
56,988
3,741
6,472
1,639
9,036
45,140
14,245
1,271
277
15,418
3,731
749
1,147
2,354
7,472
501
13,045
8,254
5,697
2,059
3,078
5,021
175
638
2,649
535
17,408
1,161
70,133
7,245
66
6,722
1,943
2,541
15,308
1,165
6,554
112
5,753
29,891
1,121
233
7,916
5,136
662
1,942
102
404,206
Table 12. Estimated numbers of persons living with HIV infection (not AIDS) or with AIDS at the end of
2004, by area of residence and age category—United States (continued)
Living with HIV infection (not AIDS)a
Area of residence
U.S. dependencies,
possessions, and
associated nations
Guam
Pacific Islands, U.S.
Puerto Rico
Virgin Islands, U.S.
Otherc
Totald
Adults or
adolescents
58
—
—
238
—
209,937
Children
<13 years old
0
—
—
1
—
2,636
Total
58
—
—
239
—
212,572
Living with AIDS
Adults or
adolescents
Children
<13 years old
36
4
10,035
293
1
413,498
0
0
43
3
0
1,695
Total
36
4
10,079
296
1
415,193
Note. These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from
adjustments of reported case counts. The reported case counts are adjusted for reporting delays. The estimates do not include
adjustment for incomplete reporting. Age category is based on age as of end of 2004.
Since 2000, the following 35 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama,
Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri,
Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota,
Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam and the U.S. Virgin Islands.
a
Includes only persons living with HIV infection that has not progressed to AIDS.
b
Florida (since July 1997) has had confidential name-based HIV infection reporting only for new diagnoses.
c
Persons reported from areas with confidential name-based AIDS reporting, who are residents of other areas.
d
Total number of persons living with HIV infection (not AIDS) includes persons reported from areas with confidential name-based HIV
infection reporting who were residents of other states or whose area of residence is unknown. Total number of persons living with
AIDS includes persons whose area of residence is unknown. Because column totals were calculated independently of the values
for the subpopulations, the values in each column may not sum to the column total.
Reports
Persons
of living
cases of
with
AIDS,
HIV/AIDS,
HIV infection,
AIDS, orand
HIV
HIV/AIDS
infection
23
Table 13. Proportion of persons surviving for more than 12, 24, and 36 months after an AIDS diagnosis
in 2000, by selected characteristics—United States
>12
No. of persons
Age at diagnosis (yrs)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
≥65
Survival in months
>24
>36
Proportion
118
60
289
1,302
3,367
6,314
8,676
7,245
4,959
2,833
1,438
774
689
0.96
1.00
0.98
0.95
0.94
0.94
0.92
0.90
0.88
0.86
0.84
0.79
0.73
0.95
0.98
0.95
0.92
0.91
0.90
0.88
0.86
0.83
0.80
0.79
0.74
0.66
0.95
0.93
0.93
0.89
0.89
0.88
0.86
0.83
0.79
0.76
0.75
0.70
0.61
Race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
10,994
18,828
7,598
340
168
0.91
0.90
0.91
0.91
0.92
0.87
0.85
0.87
0.89
0.89
0.85
0.81
0.85
0.88
0.85
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contact
Othera
Subtotal
12,777
5,406
1,768
2,963
4,975
27,889
0.92
0.87
0.92
0.91
0.87
0.90
0.89
0.82
0.87
0.87
0.83
0.86
0.87
0.78
0.83
0.84
0.81
0.84
Female adult or adolescent
Injection drug use
Heterosexual contact
Othera
Subtotal
2,560
4,782
2,715
10,057
0.89
0.92
0.90
0.91
0.83
0.88
0.85
0.86
0.77
0.85
0.82
0.82
Child (<13 yrs at diagnosis)
Perinatal
Otherb
Subtotal
104
14
118
0.95
1.00
0.96
0.94
1.00
0.95
0.94
1.00
0.95
38,064
0.90
0.86
0.83
Totalc
Note. Excludes persons whose date of death is before, or in the same month as, date of diagnosis. Excludes persons whose month
of diagnosis or month of death is unknown.
a
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified.
b
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
c
Includes 136 persons of unknown race or multiple races.
24
Reports of cases
Survival
of AIDS,
after AIDS
HIV infection,
diagnosis and HIV/AIDS
Figure 2. Proportion of persons surviving, by months after AIDS diagnosis during 1996–2003 and by
year of diagnosis—United States
Figure 3. Proportion of persons surviving, by months after AIDS diagnosis during 1996–2003 and by
age group—United States
Reports of cases
Survival
of AIDS,
after AIDS
HIV infection,
diagnosis and HIV/AIDS
25
Figure 4. Proportion of persons surviving, by months after AIDS diagnosis during 1996–2003 and by
race/ethnicity—United States
26
Reports of cases
Survival
of AIDS,
after AIDS
HIV infection,
diagnosis and HIV/AIDS
Table 14. Reported AIDS cases and annual rates (per 100,000 population), by area of residence and
age category, cumulative through 2004—United States
Cumulative through 2004a
2003
Area of residence
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Subtotal
2004
No.
Rate
No.
Rate
460
24
579
183
5,766
350
722
216
965
4,625
1,850
103
25
1,708
484
75
115
211
1,017
52
1,570
749
673
178
505
391
6
57
277
36
1,508
96
6,615
1,077
3
757
211
239
1,862
102
765
13
829
3,346
75
15
761
523
87
181
7
43,044
10.2
3.7
10.4
6.7
16.3
7.7
20.7
26.4
173.1
27.2
21.3
8.2
1.8
13.5
7.8
2.5
4.2
5.1
22.6
4.0
28.5
11.7
6.7
3.5
17.5
6.8
0.7
3.3
12.4
2.8
17.4
5.1
34.4
12.8
0.5
6.6
6.0
6.7
15.1
9.5
18.4
1.7
14.2
15.1
3.2
2.4
10.3
8.5
4.8
3.3
1.4
14.8
466
55
563
185
4,679
338
643
157
992
5,822
1,640
136
22
1,679
396
64
116
251
1,010
60
1,451
564
655
218
479
394
7
69
305
42
1,848
183
7,641
1,137
17
665
195
281
1,629
132
759
12
774
3,298
79
17
796
444
93
177
18
43,653
10.3
8.4
9.8
6.7
13.0
7.3
18.4
18.9
179.2
33.5
18.6
10.8
1.6
13.2
6.3
2.2
4.2
6.1
22.4
4.6
26.1
8.8
6.5
4.3
16.5
6.8
0.8
3.9
13.1
3.2
21.2
9.6
39.7
13.3
2.7
5.8
5.5
7.8
13.1
12.2
18.1
1.6
13.1
14.7
3.3
2.7
10.7
7.2
5.1
3.2
3.6
14.9
Adults or
adolescents
7,669
590
9,276
3,451
134,573
8,110
13,711
3,277
16,079
95,208
28,026
2,753
558
30,739
7,516
1,553
2,566
4,212
15,934
1,047
27,236
18,129
13,521
4,388
5,976
10,205
350
1,318
5,162
987
46,459
2,388
164,458
13,958
130
13,521
4,356
5,538
30,174
2,386
11,989
221
11,071
64,089
2,189
439
15,565
11,012
1,364
4,186
218
879,831
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Children
(<13 yrs)
75
7
44
36
648
31
179
25
180
1,504
222
17
2
281
53
12
13
29
132
9
314
210
110
27
56
60
3
11
28
10
765
8
2,356
120
1
134
25
19
352
27
100
5
55
390
20
6
175
34
11
31
2
8,964
Total
7,744
597
9,320
3,487
135,221
8,141
13,890
3,302
16,259
96,712
28,248
2,770
560
31,020
7,569
1,565
2,579
4,241
16,066
1,056
27,550
18,339
13,631
4,415
6,032
10,265
353
1,329
5,190
997
47,224
2,396
166,814
14,078
131
13,655
4,381
5,557
30,526
2,413
12,089
226
11,126
64,479
2,209
445
15,740
11,046
1,375
4,217
220
888,795
27
Table 14. Reported AIDS cases and annual rates (per 100,000 population), by area of residence and
age category, cumulative through 2004—United States (continued)
Cumulative through 2004a
2003
Area of residence
U.S. dependencies,
possessions, and
associated nations
Guam
Pacific Islands, U.S.
Puerto Rico
Virgin Islands, U.S.
Otherb
Totalc
No.
Rate
No.
2004
Rate
Adults or
adolescents
Children
(<13 yrs)
Total
6
1
1,065
33
0
3.7
0.7
27.5
30.3
0.0
1
0
911
20
0
0.6
0.0
23.4
18.4
0.0
67
2
27,805
584
3
1
0
397
17
0
68
2
28,202
601
3
44,262
15.0
44,737
15.0
908,905
9,381
918,286
a
Includes persons with a diagnosis of AIDS, reported from the beginning of the epidemic through 2004.
b
Persons reported from areas with confidential name-based AIDS reporting, who are residents of other areas.
c
Includes persons whose state or area of residence is unknown. Cumulative total includes 615 persons whose state or area of
residence is unknown.
28
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Table 15.
Reported AIDS cases and annual rates (per 100,000 population), by metropolitan area of residence
and age category, cumulative through 2004—United States
Cumulative through 2004
Area of residence
(Population ≥ 500,000)
2003
No.
Akron, OH MSA
Albany-Schenectady-Troy, NY MSA
Albuquerque, NM MSA
Allentown-Bethlehem-Easton, PA-NJ MSA
Atlanta-Sandy Springs-Marietta, GA MSA
Augusta-Richmond County, GA-SC MSA
Austin-Round Rock, TX MSA
Bakersfield, CA MSA
Baltimore-Towson, MD MSA
Baton Rouge, LA MSA
Birmingham-Hoover, AL MSA
Boise City-Nampa, ID MSA
Boston, MA-NH MSAa
Boston, MA-NH MSA-Boston div.
Boston, MA-NH MSA-Cambridge div.
Boston, MA-NH MSA-Essex div.
Bridgeport-Stamford-Norwalk, CT MSA
Buffalo-Niagara Falls, NY MSA
Cape Coral-Fort Myers, FL MSA
Charleston-North Charleston, SC MSA
Charlotte-Gastonia-Concord, NC-SC MSA
Chicago, IL-IN-WI MSA
Chicago, IL-IN-WI MSA-Chicago div.
Chicago, IL-IN-WI MSA-Gary div.
Chicago, IL-IN-WI MSA-Lake div.
Cincinnati-Middletown, OH-KY-IN MSA
Cleveland-Elyria-Mentor, OH MSA
Colorado Springs, CO MSA
Columbia, SC MSA
Columbus, OH MSA
Dallas, TX MSA
Dallas, TX MSA-Dallas div.
Dallas, TX MSA-Fort Worth div.
Dayton, OH MSA
Denver-Aurora, CO MSA
Des Moines, IA MSA
Detroit MI MSA
Detroit MI MSA-Detroit div.
Detroit MI MSA-Warren div.
El Paso, TX MSA
Fresno, CA MSA
Grand Rapids-Wyoming, MI MSA
Greensboro-High Point, NC MSA
Greenville, SC MSA
Harrisburg-Carlisle, PA MSA
Hartford-West Hartford-East Hartford, CT MSA
Honolulu, HI MSA
Houston-Baytown-Sugar Land, TX MSA
Indianapolis, IN MSA
Jackson, MS MSA
Jacksonville, FL MSA
Kansas City, MO-KS MSA
Knoxville, TN MSA
Lakeland, FL MSA
Las Vegas-Paradise, NV MSA
Little Rock-North Little Rock, AR MSA
Los Angeles, CA MSA
Los Angeles, CA MSA-Los Angeles div.
Los Angeles, CA MSA-Santa Anna div.
Louisville, KY-IN MSA
Madison, WI MSA
McAllen-Edinburg-Pharr, TX MSA
Memphis, TN-MS-AR MSA
Miami, FL MSA
Miami, FL MSA-Fort Lauderdale div.
Miami, FL MSA-Miami div.
Miami, FL MSA-West Palm Beach div.
Milwaukee-Waukesha-West Allis, WI MSA
Minneapolis-St. Paul-Bloomington,
MN-WI MSA
Nashville-Davidson-Murfreesboro, TN MSA
New Haven-Milford, CT MSA
New Orleans-Metairie-Kenner, LA MSA
2004
Rate
No.
Rate
Adults or
adolescents
Children
(<13 yrs)
Total
23
98
43
89
1,172
83
155
98
1,028
245
126
9
520
344
118
52
164
104
76
91
254
1,562
1,476
43
43
77
189
37
199
211
978
735
243
92
252
29
478
371
107
90
81
40
70
77
78
281
79
1,360
249
183
284
129
52
114
252
52
2,750
2,505
245
109
16
46
372
2,179
681
1,057
441
102
3.3
11.7
5.6
11.6
25.5
16.3
11.3
13.7
39.1
34.0
11.7
1.8
11.7
18.9
8.0
7.0
18.2
9.0
15.4
15.9
17.7
16.7
18.9
6.3
5.1
3.8
8.8
6.5
29.7
12.6
17.5
19.7
13.1
10.9
10.9
5.8
10.7
18.3
4.4
12.8
9.5
5.2
10.6
13.3
15.1
23.8
8.8
26.8
15.6
35.9
23.7
6.8
8.1
22.3
16.0
8.3
21.4
25.4
8.3
9.2
3.0
7.2
30.0
41.3
39.4
45.2
36.4
6.7
32
156
100
86
1,010
139
191
70
866
255
113
7
361
188
103
57
157
158
84
93
262
1,497
1,379
68
50
126
162
27
184
137
920
733
187
60
245
19
469
371
98
80
57
39
60
78
53
231
114
1,239
178
160
366
140
33
136
265
63
2,289
2,063
226
117
22
52
335
2,882
1,025
1,366
491
98
4.6
18.5
12.8
11.0
21.5
27.0
13.5
9.5
32.8
35.0
10.4
1.3
8.2
10.4
7.0
7.7
17.4
13.7
16.3
15.9
17.8
15.9
17.6
9.8
5.9
6.1
7.6
4.7
27.1
8.1
16.1
19.2
9.9
7.1
10.5
3.7
10.4
18.4
4.0
11.2
6.6
5.1
9.0
13.4
10.2
19.5
12.7
23.9
11.0
30.9
29.9
7.3
5.1
25.9
16.1
9.9
17.7
20.8
7.6
9.7
4.1
7.9
26.8
53.8
58.4
57.8
39.5
6.5
668
2,061
1,289
1,171
19,457
1,721
4,434
1,344
18,353
3,291
2,357
259
12,757
8,048
2,936
1,481
3,439
2,253
1,575
1,865
2,762
27,613
25,984
935
694
2,444
3,852
545
2,909
2,791
18,638
14,806
3,832
1,111
6,414
477
9,401
7,529
1,872
1,394
1,321
721
1,160
1,158
1,165
4,763
2,010
23,827
3,491
2,166
5,461
4,339
809
1,613
4,130
1,233
54,819
48,393
6,426
2,088
483
533
4,437
51,539
15,021
27,458
9,060
2,332
1
24
2
16
121
23
26
8
215
20
25
0
145
89
35
20
54
19
24
17
23
259
247
7
5
17
48
5
23
14
63
37
26
15
22
3
73
57
16
10
11
5
14
4
9
45
14
172
24
30
74
15
5
20
27
14
287
246
41
19
4
10
19
987
259
506
222
18
669
2,085
1,291
1,187
19,578
1,744
4,460
1,352
18,568
3,311
2,382
259
12,902
8,137
2,971
1,501
3,493
2,272
1,599
1,882
2,785
27,872
26,231
942
699
2,461
3,900
550
2,932
2,805
18,701
14,843
3,858
1,126
6,436
480
9,474
7,586
1,888
1,404
1,332
726
1,174
1,162
1,174
4,808
2,024
23,999
3,515
2,196
5,535
4,354
814
1,633
4,157
1,247
55,106
48,639
6,467
2,107
487
543
4,456
52,526
15,280
27,964
9,282
2,350
156
267
223
428
5.1
19.5
26.5
32.5
177
243
190
421
5.7
17.4
22.5
31.9
3,888
3,476
4,320
8,195
21
17
72
70
3,909
3,493
4,392
8,265
Reports of cases of AIDS, HIV infection, and HIV/AIDS
29
Table 15.
Reported AIDS cases and annual rates (per 100,000 population), by metropolitan area of residence
and age category, cumulative through 2004—United States (continued)
Cumulative through 2004
Area of residence
(Population ≥ 500,000)
2003
No.
New York, NY-NJ-PA
6,853
New York, NY-NJ-PA MSA-Edison div.
183
New York, NY-NJ-PA MSA-Nassau div.
266
New York, NY-NJ-PA MSA-Newark div.
541
New York, NY-NJ-PA MSA-New York div.
5,863
Oklahoma City, OK MSA
97
Omaha-Council Bluffs, NE-IA MSA
41
Orlando, FL MSA
483
Oxnard-Thousand Oaks-Ventura, CA MSA
32
Palm Bay-Melbourne-Titusville, FL MSA
77
Phil., PA-NJ-DE-MD MSA
1,437
Phil., PA-NJ-DE-MD MSA-Camden div.
150
Phil., PA-NJ-DE-MD MSA-Phil. div.
1,108
Phil., PA-NJ-DE-MD MSA-Wilmington div.
179
Phoenix-Mesa-Scottsdale, AZ MSA
399
Pittsburgh, PA MSA
245
Portland-South Portland, ME MSA
25
Portland-Vancouver-Beaverton, OR-WA MSA
180
Poughkeepsie-Newburgh-Middletown,
NY MSA
123
Providence-New Bedford-Fall River,
RI-MA MSA
147
Raleigh-Cary, NC MSA
154
Richmond, VA MSA
142
Riverside-San Bernardino-Ontario, CA MSA
464
Rochester, NY MSA
132
Sacramento-Arden-Arcade-Roseville, CA MSA
148
St. Louis, MO-IL MSA
219
Salt Lake City, UT MSA
54
San Antonio, TX MSA
169
San Diego-Carlsbad-San Marcos, CA MSA
503
San Francisco, CA MSA
1,123
San Francisco, CA MSA-Oakland div.
370
San Francisco, CA MSA-San Francisco div.
753
San Jose-Sunnyvale-Santa Clara, CA MSA
114
San Juan-Caguas-Guaynabo, PR MSA
808
Sarasota-Bradenton-Venice, FL MSA
121
Scranton-Wilkes-Barre, PA MSA
34
Seattle, WA MSA
409
Seattle, WA MSA-Seattle div.
375
Seattle, WA MSA-Tacoma div.
34
Springfield, MA MSA
89
Stockton, CA MSA
75
Syracuse, NY MSA
49
Tampa-St. Petersburg-Clearwater, FL MSA
547
Toledo, OH MSA
38
Tucson, AZ MSA
115
Tulsa, OK MSA
65
Virginia Beach-Norfolk-Newport News,
VA-NCMSA
160
Washington, DC-VA-MD-WV MSA
1,723
Washington, DC-VA-MD-WV
MSA-Bethesda div.
143
Washington, DC-VA-MD-WV
MSA-Wash. div.
1,580
Wichita, KS MSA
41
Worcester, MA MSA
74
Youngstown-Warren-Boardman, OH-PA MSA
22
Metropolitan Areas With 500,000 Or More
Population
36,332
Metropolitan Areas With 50,000 To
499,999 Population
4,651
Nonmetropolitan
2,882
Totalb
44,109
2004
Rate
No.
Rate
Adults or
adolescents
Children
(<13 yrs)
Total
36.7
8.1
9.5
25.2
51.2
8.6
5.2
26.8
4.0
15.2
24.9
12.2
28.6
26.6
11.1
10.2
4.9
8.8
7,837
233
392
718
6,494
69
47
581
44
65
1,312
146
1,032
134
431
136
22
216
41.9
10.2
13.9
33.4
56.7
6.0
5.8
31.2
5.5
12.5
22.6
11.8
26.6
19.7
11.6
5.7
4.3
10.5
184,528
6,400
7,627
19,034
151,467
2,039
921
7,695
942
1,400
25,695
2,903
20,004
2,788
6,668
2,917
532
4,473
2,896
135
115
329
2,317
5
3
86
3
11
302
41
240
21
29
19
1
9
187,424
6,535
7,742
19,363
153,784
2,044
924
7,781
945
1,411
25,997
2,944
20,244
2,809
6,697
2,936
533
4,482
18.8
208
31.3
2,898
24
2,922
9.1
17.4
12.5
12.7
12.7
7.5
8.0
5.4
9.3
17.2
27.0
15.0
44.4
6.6
31.6
19.1
6.2
13.0
15.6
4.6
12.9
11.9
7.5
21.6
5.8
12.9
7.4
180
158
173
331
178
87
236
57
191
412
868
302
566
66
624
94
38
318
281
37
65
59
43
664
45
77
69
11.1
17.3
15.0
8.7
17.1
4.3
8.5
5.6
10.3
14.1
20.9
12.3
33.5
3.8
24.3
14.4
6.9
10.0
11.6
5.0
9.4
9.1
6.6
25.7
6.8
8.5
7.8
3,630
1,674
3,129
7,948
2,850
3,681
5,422
1,667
4,566
12,071
38,742
9,000
29,742
3,516
20,197
1,813
489
8,603
7,650
953
1,973
977
1,213
10,132
727
1,798
1,350
43
13
34
59
13
24
40
10
30
60
94
47
47
15
277
26
5
27
18
9
24
13
9
110
13
10
9
3,673
1,687
3,163
8,007
2,863
3,705
5,462
1,677
4,596
12,131
38,836
9,047
29,789
3,531
20,474
1,839
494
8,630
7,668
962
1,997
990
1,222
10,242
740
1,808
1,359
9.8
34.0
161
1,797
9.8
35.0
4,394
28,456
62
302
4,456
28,758
12.7
185
16.2
2,489
22
2,511
40.1
7.0
9.5
3.7
1,612
41
82
40
40.3
7.0
10.5
6.8
25,967
782
1,648
477
280
2
20
0
26,247
784
1,668
477
19.1
36,226
18.9
768,755
8,054
776,809
8.4
5.8
15.0
4,887
3,110
44,564
8.8
6.2
15.0
86,877
47,301
907,636
834
441
9,361
87,711
47,742
916,997
Note. Includes persons from 50 States, the District of Columbia, and Puerto Rico, because of the lack of census information for the U.S dependencies,
possessions, and associated nations.
a
b
Reported case counts for the metropolitan divisions do not sum to the MSA total. MSA total includes data from one metropolitan division with population <500,000.
Includes persons whose county of residence is unknown.
MSA definitions for this report can be found at http://www.census.gov/population/estimates/metro-city/List4.txt.
30
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Table 16. Reported cases of HIV infection (not AIDS), by area of residence and age category,
cumulative through 2004—42 areas with confidential name-based HIV infection reporting
Cumulative through 2004a
Area of residence
(Date HIV reporting initiated)
Alabama (Jan. 1988)
Alaska (Feb. 1999)
Arizona (Jan. 1987)
Arkansas (July 1989)
Colorado (Nov. 1985)
Connecticut (July 1992)b
Florida (July 1997)c
Georgia (Dec. 2003)
Idaho (June 1986)
Indiana (July 1988)
Iowa (July 1998)
Kansas (July 1999)
Kentucky (Oct. 2004)
Louisiana (Feb. 1993)
Michigan (April 1992)
Minnesota (Oct. 1985)
Mississippi (Aug. 1988)
Missouri (Oct. 1987)
Nebraska (Sept. 1995)
Nevada (Feb. 1992)
New Jersey (Jan. 1992)
New Mexico (Jan. 1998)
New York (June 2000)
North Carolina (Feb. 1990)
North Dakota (Jan. 1988)
Ohio (June 1990)
Oklahoma (June 1988)
Pennsylvania (Oct. 2002)d
South Carolina (Feb. 1986)
South Dakota (Jan. 1988)
Tennessee (Jan. 1992)
Texas (Jan. 1999)e
Utah (April 1989)
Virginia (July 1989)
West Virginia (Jan. 1989)
Wisconsin (Nov. 1985)
Wyoming (June 1989)
Subtotal
U.S. dependencies, possessions,
and associated nations
American Samoa (Aug. 2001)
Guam (March 2000)
Northern Mariana Islands (Oct. 2001)
Puerto Rico (Jan. 2003)
Virgin Islands, U.S. (Dec. 1998)
Persons reported from areas with confidential
name-based HIV infection reporting, who were
residents of other areas
Totalf
2004
No.
Adults or
adolescents
Children
(<13 yrs)
Total
488
45
508
163
371
0
5,107
2,154
22
372
64
114
390
902
602
225
340
408
43
313
1,704
161
6,033
1,099
11
800
125
1,330
571
12
780
4,143
93
858
65
180
8
30,604
5,684
252
5,111
2,129
5,941
—
32,712
2,492
330
3,771
500
1,083
588
7,912
6,242
3,086
4,249
4,655
594
3,139
16,300
822
36,949
12,236
82
7,491
2,313
4,459
6,897
186
6,816
20,430
735
9,121
629
2,357
82
218,375
45
2
67
18
28
102
336
98
4
44
5
15
10
137
134
36
55
49
10
19
431
3
1,874
132
1
95
30
61
94
3
88
387
12
88
7
30
1
4,551
5,729
254
5,178
2,147
5,969
102
33,048
2,590
334
3,815
505
1,098
598
8,049
6,376
3,122
4,304
4,704
604
3,158
16,731
825
38,823
12,368
83
7,586
2,343
4,520
6,991
189
6,904
20,817
747
9,209
636
2,387
83
222,926
0
2
0
2,049
27
1
61
5
2,923
247
0
0
0
37
5
1
61
5
2,960
252
421
1,977
165
2,142
33,563
224,597
4,814
229,411
Note. Includes only persons with HIV infection that has not progressed to AIDS. Includes data from 37 states and from U.S.
dependencies, possessions, and independent nations.
a
Includes persons with a diagnosis of HIV infection, reported from the beginning of the epidemic through 2004.
b
Connecticut has confidential name-based HIV infection reporting only for pediatric cases.
c
Florida (since July 1997) has had confidential name-based HIV infection reporting only for new diagnoses.
d
Pennsylvania (October 2002) implemented confidential name-based HIV infection reporting only in areas outside the city
of Philadelphia.
e
Texas (February 1994 through December 1998) reported only pediatric HIV infection cases.
f
Includes 1,057 persons reported from areas with confidential name-based HIV infection reporting, but whose area of residence is
unknown. Includes 7 children reported from Oregon prior to the change in 2001 from name-based HIV infection reporting for pediatric
cases to code-based reporting for all persons with HIV infection.
Reports of cases of AIDS, HIV infection, and HIV/AIDS
31
Table 17. Reported AIDS cases, by age category, transmission category, and sex, cumulative through
2004—United States
Males
2004
Transmission category
Adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion, blood
components, or tissueb
Other/risk factor not reported or identifiedc
Subtotal
Child (<13 yrs at diagnosis)
Hemophilia/coagulation disorder
Mother with the following risk factor for,
or documented, HIV infection:
Injection drug use
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion, blood
components, or tissue
Has HIV infection, risk factor not specified
Receipt of blood transfusion, blood
components, or tissueb
Other/risk factor not reported or identifiedd
Subtotal
Total
No.
Females
Cumulative
through 2004 a
%
No.
Total
Cumulative
through 2004 a
2004
%
No.
%
No.
%
Cumulative
through 2004a
2004
No.
%
No.
%
15,607
4,564
48
14
402,722
155,872
55
21
—
2,355
—
20
—
63,181
—
37
15,607
6,919
35
16
402,722
219,053
44
24
1,696
71
3,373
5
0
10
60,038
5,096
43,347
8
1
6
—
21
5,278
—
0
45
—
331
74,540
—
0
43
1,696
92
8,651
4
0
19
60,038
5,427
117,887
7
1
13
435
0
4
29
1
0
0
0
11,048
0
78
517
1
0
0
0
871
251
15
37
7
2
0
0
24,568
4,617
478
733
14
3
0
0
1,306
251
19
66
3
1
0
0
35,616
4,617
556
1,250
4
1
0
0
2,905
9
31,704
4
4,104
35
44,144
26
7,009
16
75,848
8
90
7,355
32,756
0
22
100
5,163
65,062
737,300
1
9
100
106
4,099
11,859
1
35
100
4,111
29,440
171,603
2
17
100
196
11,454
44,615
0
26
100
9,274
94,504
908,905
1
10
100
0
0
223
5
0
0
7
0
0
0
230
2
51
84
4,243
89
53
87
4,333
94
104
85
8,576
91
12
6
1
0
0
20
10
2
0
0
1,653
776
94
21
11
34
16
2
0
0
7
6
1
1
1
11
10
2
2
2
1,643
742
101
16
16
36
16
2
0
0
19
12
2
1
1
16
10
2
1
1
3,296
1,518
195
37
27
35
16
2
0
0
17
28
718
15
11
18
747
16
28
23
1,465
16
0
15
0
25
69
901
1
19
1
25
2
41
82
986
2
21
1
40
1
33
151
1,887
2
20
0
10
61
0
16
100
244
84
4,794
5
2
100
0
8
61
0
13
100
144
103
4,587
3
2
100
0
18
122
0
15
100
388
187
9,381
4
2
100
32,817
100
742,094
100
11,920
100
176,190
100
44,737
100
918,286
100
a
Includes persons with a diagnosis of AIDS, reported from the beginning of the epidemic through 2004. Cumulative total includes 2 persons of unknown sex.
b
AIDS developed in 47 adults/adolescents and 3 children after they received blood that had tested negative for HIV antibodies. AIDS developed in 14
additional adults after they received tissue, organs, or artificial insemination from HIV-infected donors. Four of the 14 received tissue or organs from a
donor who was negative for HIV antibody at the time of donation.
c
Includes 36 adults/adolescents who were exposed to HIV-infected blood, body fluids, or concentrated virus in health care, laboratory, or household
settings, as supported by seroconversion, epidemiologic, and/or laboratory evidence. One person was infected after intentional inoculation with
HIV-infected blood. For an additional 424 persons who acquired HIV infection perinatally, AIDS was diagnosed after age 12. These 424 persons are
tabulated under the adult/adolescent, not the pediatric, transmission category.
d
Includes 5 children who were exposed to HIV-infected blood as supported by seroconversion, epidemiologic, and/or laboratory evidence: 1 child was
infected after intentional inoculation with HIV-infected blood and 4 children were exposed to HIV-infected blood in a household setting. Of the 187 children,
23 had sexual contact with an adult with or at high risk for HIV infection.
32
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Table 18. Reported cases of HIV infection (not AIDS), by age category, transmission category, and sex, cumulative
through 2004—42 areas with confidential name-based HIV infection reporting
Males
Cumulative
through 2004 a
2004
Transmission category
No.
Adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion, blood
components, or tissue
Other/risk factor not reported or identified
Subtotal
Child (<13 yrs at diagnosis)
Hemophilia/coagulation disorder
Mother with the following risk factor for,
or documented, HIV infection
Injection drug use
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion, blood
components, or tissue
Has HIV infection, risk factor not specified
Receipt of blood transfusion, blood
components, or tissue
Other/risk factor not reported or identified
Subtotal
Total
Females
Total
Cumulative
through 2004 a
2004
%
No.
%
No.
%
No.
%
11,601
2,675
50
12
76,003
19,989
48
13
—
1,267
—
13
—
11,719
—
17
878
29
2,014
4
0
9
8,298
474
13,564
5
0
9
—
7
4,090
—
0
41
—
62
30,644
293
0
6
17
1
0
0
0
2,330
0
29
124
1
0
0
0
666
189
14
26
7
2
0
0
1,698
7
11,081
7
3,195
46
6,015
23,258
0
26
100
468
38,251
157,047
0
24
100
4
2
106
160
78
25
10
5
1
1
12
5
2
0
0
45
Cumulative
through 2004a
2004
No.
%
No.
%
11,601
3,942
35
12
76,003
31,709
34
14
—
0
45
878
36
6,104
3
0
18
8,298
536
44,208
4
0
20
6,063
1,822
182
186
9
3
0
0
959
189
20
43
3
1
0
0
8,393
1,822
211
310
4
1
0
0
32
22,391
33
4,893
15
33,472
15
64
4,446
9,874
1
45
100
546
24,572
67,543
1
36
100
110
10,461
33,132
0
32
100
1,014
62,829
224,597
0
28
100
4
0
0
1
0
4
1
107
2
1,991
84
184
81
2,123
87
344
80
4,114
85
523
200
30
3
6
22
8
1
0
0
23
15
2
0
0
10
7
1
0
0
532
200
21
7
4
22
8
1
0
0
48
25
7
1
1
11
6
2
0
0
1,055
400
51
10
10
22
8
1
0
0
22
457
19
44
19
524
22
89
21
981
20
0
73
0
36
17
755
1
32
1
99
0
44
17
818
1
34
1
172
0
40
34
1,573
1
33
2
39
205
1
19
100
25
262
2,384
1
11
100
1
41
226
0
18
100
23
283
2,430
1
12
100
3
80
431
1
19
100
48
545
4,814
1
11
100
23,463
100
159,431
100
10,100
100
69,973
100
33,563
100
229,411
100
Note. Includes only persons with HIV infection that has not progressed to AIDS.
Since 2004, the following 42 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona,
Arkansas, Colorado, Connecticut, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska,
Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Puerto Rico, South Carolina, South Dakota,
Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, American Samoa, Guam, Northern Mariana Islands, and the U.S. Virgin Islands.
Connecticut has confidential name-based HIV infection reporting only for pediatric cases.
Florida (since July 1997) has had confidential name-based HIV infection reporting only for new diagnoses.
Pennsylvania (October 2002) implemented confidential name-based HIV infection reporting only in areas outside the city of Philadelphia.
Texas (February 1994 through December 1998) reported only pediatric HIV infection cases.
a
Includes persons with a diagnosis of HIV infection (not AIDS), reported from the beginning of the epidemic through December 2004. Cumulative total
includes 7 persons of unknown sex.
Reports of cases of AIDS, HIV infection, and HIV/AIDS
33
Table 19.
Reported AIDS cases for male adults and adolescents, by transmission category and race/ethnicity,
cumulative through 2004—United States
White, not Hispanic
Cumulative
through 2004 a
2004
Transmission category
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
Sex with injection drug user
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
Total
Black, not Hispanic
No.
%
7,369
933
66
8
760
43
416
No.
Hispanic
Cumulative
through 2004 a
2004
%
No.
%
No.
%
242,529
30,632
73
9
4,671
2,289
34
17
94,831
80,347
7
0
4
29,220
3,931
7,130
9
1
2
573
17
2,115
4
0
15
76
1
1
0
2,198
36
1
0
239
2
7
0
178
0
332
3
4,718
26
0
3,182
Cumulative
through 2004a
2004
No.
%
No.
%
37
31
3,200
1,295
45
18
58,981
44,012
43
32
20,212
598
26,096
8
0
10
305
10
782
4
0
11
9,838
454
9,562
7
0
7
2
0
6,487
30
3
0
110
1
2
0
2,247
11
2
0
14
0
209
0
7
0
115
0
1
1,860
13
19,370
7
664
9
7,189
5
1
41
0
1,197
0
19
0
640
0
1,610
14
14,980
5
4,127
30
35,801
14
1,479
21
13,073
10
11,157
100
331,604
100
13,833
100
259,082
100
7,090
100
136,560
100
Asian/Pacific Islander
American Indian/Alaska Native
Cumulative
through 2004 a
2004
Cumulative
through 2004 a
2004
Total
Cumulative
through 2004a
2004b
Transmission category
No.
%
No.
%
No.
%
No.
%
No.
%
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
228
13
58
3
4,144
288
69
5
70
22
47
15
1,302
369
55
16
15,607
4,564
48
14
402,722
155,872
55
21
16
1
32
4
0
8
244
67
326
4
1
5
23
0
14
16
0
9
402
31
103
17
1
4
1,696
71
3,373
5
0
10
60,038
5,096
43,347
8
1
6
2
0
1
0
57
1
1
0
6
0
4
0
33
0
1
0
435
4
1
0
11,048
78
1
0
0
0
8
0
0
0
3
0
29
0
517
0
30
8
260
4
8
5
67
3
2,905
9
31,704
4
3
1
118
2
1
1
9
0
90
0
5,163
1
Sex with injection drug user
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
No.
%
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
102
26
810
14
18
12
140
6
7,355
22
65,062
9
Total
395
100
5,997
100
148
100
2,356
100
32,756
100
737,300
100
a
Includes persons with a diagnosis of AIDS, reported from the beginning of the epidemic through 2004. Cumulative total includes 1,701 males of
unknown race or multiple races.
b
Total includes 133 males of unknown race or multiple races.
34
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Table 20.
Reported cases of HIV infection (not AIDS) for male adults and adolescents, by transmission
category and race/ethnicity, cumulative through 2004—42 areas with confidential name-based
HIV infection reporting
White, not Hispanic
2004
Transmission category
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
Sex with injection drug user
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
Black, not Hispanic
Cumulative
through 2004 a
No.
%
5,729
506
68
6
453
17
246
No.
Hispanic
Cumulative
through 2004 a
2004
%
No.
%
No.
%
41,771
4,660
66
7
3,459
1,004
37
11
22,485
10,417
5
0
3
4,314
341
2,094
7
1
3
240
9
1,173
3
0
13
51
1
1
0
493
7
1
0
150
1
5
0
31
0
189
2
1,563
11
0
194
Cumulative
through 2004a
2004
No.
%
No.
%
34
16
2,212
1,144
44
23
10,399
4,709
43
19
2,871
103
9,089
4
0
14
171
1
562
3
0
11
948
24
2,195
4
0
9
2
0
1,435
15
2
0
87
4
2
0
369
7
2
0
8
0
77
0
4
0
14
0
2
1,014
11
7,562
11
467
9
1,805
7
0
27
0
213
0
8
0
49
0
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
1,477
18
9,644
15
3,460
37
21,528
32
978
19
5,895
24
Total
8,439
100
63,018
100
9,372
100
66,706
100
5,076
100
24,219
100
Asian/Pacific Islander
Cumulative
through 2004 a
2004
Transmission category
No.
%
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
123
8
60
4
6
1
16
Sex with injection drug user
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
Total
American Indian/Alaska Native
No.
Cumulative
through 2004 a
2004
%
No.
%
No.
%
554
45
57
5
56
7
59
7
417
83
3
0
8
21
2
66
2
0
7
5
0
8
5
0
8
1
0
0
0
8
0
1
0
3
0
0
0
2
0
15
7
56
0
0
3
Total
Cumulative
through 2004a
2004b
No.
%
No.
%
55
11
11,601
2,675
50
12
76,003
19,989
48
13
100
0
49
13
0
6
878
29
2,014
4
0
9
8,298
474
13,564
5
0
9
3
0
15
0
2
0
293
6
1
0
2,330
29
1
0
0
0
0
0
17
0
124
0
6
5
5
34
4
1,698
7
11,081
7
0
0
0
2
0
46
0
468
0
51
25
284
29
19
20
110
14
6,015
26
38,251
24
205
100
975
100
95
100
761
100
23,258
100
157,047
100
Note. Includes only persons with HIV infection that has not progressed to AIDS.
Since 2004, the following 42 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska,
Arizona, Arkansas, Colorado, Connecticut, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Mississippi,
Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Puerto Rico,
South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, American Samoa, Guam, Northern Mariana
Islands, and the U.S. Virgin Islands.
Connecticut has confidential name-based HIV infection reporting only for pediatric cases.
Florida (since July 1997) has had confidential name-based HIV infection reporting only for new diagnoses.
Pennsylvania (October 2002) implemented confidential name-based HIV infection reporting only in areas outside the city of Philadelphia.
Texas (February 1994 through December 1998) reported only pediatric HIV infection cases.
a
Includes persons with a diagnosis of HIV infection (not AIDS), reported from the beginning of the epidemic through December 2004. Cumulative
total includes 1,368 males of unknown race or multiple races.
b
Total includes 71 males of unknown race or multiple races.
Reports of cases of AIDS, HIV infection, and HIV/AIDS
35
Table 21.
Reported AIDS cases for female adults and adolescents, by transmission category and
race/ethnicity, cumulative through 2004—United States
White, not Hispanic
Cumulative
through 2004 a
2004
Transmission category
No.
%
Injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
604
2
796
31
0
40
192
50
7
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
Total
Black, not Hispanic
No.
No.
%
No.
%
13,985
117
14,324
40
0
41
1,268
13
3,355
17
0
44
36,710
139
43,319
10
3
0
5,363
1,714
318
15
5
1
478
158
6
6
2
0
5
0
331
1
20
542
27
6,598
19
22
1
1,858
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
Cumulative
through 2004 a
2004
No.
%
No.
%
36
0
42
445
4
1,021
21
0
49
11,979
63
15,937
37
0
49
12,843
2,053
110
13
2
0
186
36
2
9
2
0
6,115
728
44
19
2
0
0
252
0
7
0
118
0
2,693
35
28,061
27
790
38
8,932
27
5
66
1
1,516
1
17
1
610
2
548
28
4,393
13
2,884
38
20,423
20
597
29
4,212
13
1,972
100
34,677
100
7,586
100
102,107
100
2,084
100
32,801
100
American Indian/Alaska Native
Cumulative
through 2004a
2004
Injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
Cumulative
through 2004 a
2004
%
Asian/Pacific Islander
Transmission category
Hispanic
Cumulative
through 2004a
2004
No.
%
Total
Cumulative
through 2004 a
2004b
No.
%
No.
%
No.
%
No.
%
7
1
47
7
1
47
115
7
489
12
1
52
21
1
30
34
2
48
256
3
246
43
1
41
2,355
21
5,278
20
0
45
63,181
331
74,540
No.
37
0
43
%
7
3
0
7
3
0
108
80
4
11
9
0
7
3
0
11
5
0
92
29
2
15
5
0
871
251
15
7
2
0
24,568
4,617
478
14
3
0
2
2
22
2
2
3
5
1
37
0
733
0
35
35
275
29
18
29
118
20
4,104
35
44,144
26
1
1
94
10
0
0
14
2
106
1
4,111
2
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
43
43
235
25
10
16
78
13
4,099
35
29,440
17
Total
99
100
940
100
62
100
597
100
11,859
100
171,603
100
a
Includes persons with a diagnosis of AIDS, reported from the beginning of the epidemic through 2004. Cumulative total includes 481 females of
unknown race or multiple races.
b
Total includes 56 females of unknown race or multiple races.
36
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Table 22.
Reported cases of HIV infection (not AIDS) for female adults and adolescents, by transmission
category and race/ethnicity, cumulative through 2004—42 areas with confidential name-based
HIV infection reporting
White, not Hispanic
Black, not Hispanic
Cumulative
through 2004 a
2004
Hispanic
Cumulative
through 2004 a
2004
Transmission category
No.
%
No.
%
No.
%
No.
%
Injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
341
0
667
21
0
40
3,513
20
6,236
26
0
46
546
5
2,358
9
0
39
6,223
31
19,445
147
50
5
9
3
0
1,685
540
106
12
4
1
273
110
8
4
2
0
5
0
53
0
19
460
28
3,852
28
9
1
144
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
Total
No.
%
No.
%
14
0
45
368
2
1,003
19
0
51
1,816
9
4,505
19
0
48
3,269
1,075
63
8
2
0
233
27
1
12
1
0
1,018
177
9
11
2
0
0
100
0
2
0
31
0
1,948
32
14,938
35
740
38
3,270
35
1
43
1
332
1
12
1
62
1
646
39
3,772
28
3,144
52
17,254
40
576
29
3,029
32
1,663
100
13,685
100
6,096
100
43,285
100
1,961
100
9,421
100
Asian/Pacific Islander
Injection drug use
Hemophilia/coagulation disorder
Heterosexual contact
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion
recipient
Sex with HIV-infected person,
risk factor not specified
American Indian/Alaska Native
Cumulative
through 2004 a
2004
Transmission category
Cumulative
through 2004a
2004
Cumulative
through 2004 a
2004
No.
%
No.
%
No.
%
No.
%
3
0
30
4
0
40
18
1
138
5
0
42
3
0
17
8
0
45
87
0
139
3
1
0
4
1
0
10
7
0
3
2
0
2
1
0
5
3
0
0
0
1
0
0
26
35
120
36
0
0
5
Total
Cumulative
through 2004a
2004b
No.
%
No.
%
28
0
45
1,267
7
4,090
13
0
41
11,719
62
30,644
17
0
45
49
10
2
16
3
1
666
189
14
7
2
0
6,063
1,822
182
9
3
0
0
0
0
26
0
186
0
14
37
78
25
3,195
32
22,391
33
2
0
0
1
0
64
1
546
1
Receipt of blood transfusion,
blood components, or tissue
Other/risk factor not reported
or identified
42
56
169
51
18
47
80
26
4,446
45
24,572
36
Total
75
100
331
100
38
100
307
100
9,874
100
67,543
100
Note. Includes only persons with HIV infection that has not progressed to AIDS.
Since 2004, the following 42 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska,
Arizona, Arkansas, Colorado, Connecticut, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Michigan, Minnesota, Mississippi,
Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Puerto Rico,
South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, American Samoa, Guam, Northern Mariana
Islands, and the U.S. Virgin Islands.
Connecticut has confidential name-based HIV infection reporting only for pediatric cases.
Florida (since July 1997) has had confidential name-based HIV infection reporting only for new diagnoses.
Pennsylvania (October 2002) implemented confidential name-based HIV infection reporting only in areas outside the city of Philadelphia.
Texas (February 1994 through December 1998) reported only pediatric HIV infection cases.
a
Includes persons with a diagnosis of HIV infection (not AIDS), reported from the beginning of the epidemic through December 2004.
Cumulative total includes 514 females of unknown race or multiple races.
b
Total includes 41 females of unknown race or multiple races.
Reports of cases of AIDS, HIV infection, and HIV/AIDS
37
Table 23. Reported cases of HIV/AIDS in infants born to HIV-infected mothers, by year of report and
selected characteristics, 1994–2004—25 states with confidential name-based HIV infection
reporting
Year of report
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
80
223
33
1
5
74
211
20
1
1
49
169
19
0
0
26
139
14
2
1
30
100
13
2
0
20
82
12
0
1
14
86
16
1
0
20
91
15
0
0
22
69
19
1
1
16
64
8
1
1
9
60
15
0
0
130
70
7
2
1
94
45
10
2
0
84
42
5
0
0
59
28
5
0
0
28
17
2
1
0
27
21
5
1
0
30
11
2
1
0
26
10
5
1
0
13
11
2
0
0
8
6
5
1
0
5
6
4
0
0
81
91
52
56
53
30
43
50
39
39
32
5
47
3
63
3
51
3
34
2
42
1
32
0
30
2
32
1
47
0
34
0
37
Child’s diagnosis statusa
HIV infection
AIDS
144
199
150
158
134
103
110
75
104
41
78
39
90
27
88
38
77
36
75
18
70
14
Totalb
343
308
237
185
145
117
117
126
113
93
84
Child’s race/ethnicity
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Perinatal transmission category
Mother with the following risk factor for,
or documented, HIV infection:
Injection drug use
Sex with injection drug user
Sex with bisexual male
Sex with person with hemophilia
Sex with HIV-infected transfusion recipient
Sex with HIV-infected person,
risk factor not specified
Receipt of blood transfusion, blood
components, or tissue
Has HIV infection, risk factor not specified
Note. Since 1994, the following 25 states have had laws and regulations requiring confidential name-based HIV infection reporting:
Alabama, Arkansas, Arizona, Colorado, Idaho, Indiana, Louisiana, Michigan, Minnesota, Missouri, Mississippi, North Carolina, North Dakota,
New Jersey, Nevada, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming.
Data include children with a diagnosis of HIV infection. This includes children with a diagnosis of HIV infection only, a diagnosis of HIV
infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.
a
Status in the surveillance system as of June 2005.
b
Includes children of unknown race or multiple races.
38
Reports of cases of AIDS, HIV infection, and HIV/AIDS
Technical Notes
Surveillance of HIV Infection (not AIDS)
This report includes data from case reports from
42 areas that had laws or regulations requiring
confidential reporting by name for adults and adolescents and/or children with confirmed HIV infection
(not AIDS), in addition to the reporting of persons
with AIDS. Connecticut required reporting by name
for children 13 years of age and younger. After the
removal of personal identifying information, data from
these reports were submitted to CDC (see Table 16
for list of areas). The implementation of HIV
reporting has differed from state to state. Before
1991, surveillance of HIV infection (not AIDS) was
not standardized, and the reporting of HIV infections
(not AIDS) was based primarily on passive surveillance. The information on many of the cases reported before 1991 is not complete. Since then, CDC
has assisted states in conducting active surveillance
of HIV infections (not AIDS) by the use of standardized report forms and software.
Data on HIV infection (not AIDS) should be
interpreted with caution. HIV surveillance reports
may not be representative of all persons infected with
HIV because not all infected persons have been
tested. Many HIV-reporting states offer anonymous
HIV testing; the results of anonymous tests are not
reported to the confidential name-based HIV registries of state and local health departments. Therefore, reports of confidential test results may not
represent all persons who tested positive for HIV
infection. Furthermore, many factors, including the
extent to which testing is routinely offered to specific
groups and the availability of, and access to, medical
care and testing services, may influence testing
patterns. These data provide a minimum estimate of
the number of persons known to be HIV infected in
states with confidential HIV reporting.
As of December 31, 2004, 8 areas (California,
Hawaii, Illinois, Maryland, Massachusetts, Rhode
Island, Vermont, and the District of Columbia) had
implemented a code-based system to conduct case
surveillance for HIV infection (not AIDS). Other
areas (Delaware, Maine, Montana, Oregon, and
Washington) had implemented a name-to-code
system for conducting HIV infection surveillance:
initially, names are collected, and, after any necessary
public health follow-up, names are converted to
codes. Connecticut allows cases of HIV infection
(not AIDS) in adults and adolescents to be reported
by name or code; New Hampshire allows HIV cases
to be reported with or without a name. Data on
cases of HIV infection (not AIDS) from these areas
are not included in the HIV data tables pending
evaluations demonstrating acceptable performance
according to CDC guidelines and pending the development of methods for reporting such data to CDC.
For this report, we classified cases in adults,
adolescents, and children 18 months of age and older
by using the 2000 revised HIV surveillance case
definition, which incorporates positive test results or
reports of a detectable quantity of HIV nucleic acid
or plasma HIV RNA [1]. For children less than 18
months of age, the pediatric HIV reporting criteria
reflect diagnostic advances that permit the diagnosis
of HIV infection during the first months of life. By
the use of HIV nucleic acid detection tests, HIV
infection can be detected in nearly all infants aged 1
month and older. The timing of the HIV serologic
and HIV nucleic acid detection tests specified in the
definitive and presumptive criteria for HIV infection
is based on the recommended practices for diagnosing infection in children aged less than 18 months and
on evaluations of the performance of these tests for
children in this age group. Children aged less than 18
months born to an HIV-infected mother are categorized as having been exposed perinatally to HIV
infection if the child does not meet the criteria for
HIV infection or the criteria for “not infected with
HIV” [1, 2]. Children born before 1994 were
considered HIV infected if they met the HIV case
definition in the 1987 pediatric classification system
for HIV infection [3].
Because states initiated reporting on different
dates, the length of time reporting has been in place
influences the number of HIV infection cases reported. For example, data presented for a given year
may include cases reported during only a part of the
year. Before statewide HIV reporting, some states
collected reports of HIV infection (not AIDS) in
selected populations. Therefore, these states have
reports that precede the initiation of statewide
confidential reporting. A state with confidential HIV
infection reporting also may report persons who
tested positive in that state but who were residents of
Reports of cases of AIDS,
Technical
HIV infection,
Notes and HIV/AIDS
39
other states. Therefore, when HIV data are presented by state of residence, cases reported before a
state initiated reporting may have been reported from
other states that did have confidential HIV infection
reporting.
Over time, HIV infection may progress to AIDS
and be reported to surveillance. Persons with HIV
infection (not AIDS) who are later reported as having
AIDS are deleted from the HIV infection (not AIDS)
tables and added to the AIDS tables. Persons with
HIV infection may be tested at any point on the
clinical spectrum of disease; therefore, the time
between diagnosis of HIV infection and diagnosis of
AIDS differs. In addition, because surveillance
practices differ, the reporting and updating of persons’
clinical and vital status differ among states. Completeness of reporting for HIV infection (not AIDS) is
estimated at more than 85% [4].
Surveillance of AIDS
All 50 states, the District of Columbia, and U.S.
dependencies, possessions, and associated nations
report AIDS cases to CDC by using a uniform
surveillance case definition and case report form.
The original definition was modified in 1985 and 1987
[5, 6]. The case definition for adults and adolescents
was modified again in 1993 [7; see also 8]. The
revisions incorporated a broader range of AIDSindicator diseases and conditions and used HIV
diagnostic tests to improve the sensitivity and specificity of the definition. The laboratory and diagnostic
criteria for the 1987 pediatric case definition [3] were
updated in 1994 [9]. Effective January 1, 2000, the
surveillance case definition for HIV infection was
revised to reflect advances in laboratory HIV virologic tests. The definition incorporates the reporting
criteria for HIV infection and AIDS into a single case
definition for adults and children [1].
For persons with laboratory-confirmed HIV
infection, the 1987 revision incorporated encephalopathy, wasting syndrome, and other indicator diseases
that are diagnosed presumptively (i.e., without
confirmatory laboratory evidence of opportunistic
infection). In addition to the 23 clinical conditions in
the 1987 definition, the 1993 case definition for adults
and adolescents includes HIV infection among
persons with CD4+ T-lymphocyte counts of less than
200 cells/µL or a CD4+ percentage of less than 14
and a diagnosis of pulmonary tuberculosis, recurrent
pneumonia, or invasive cervical cancer. For adults,
40
adolescents, and children 18 months of age and older,
the 2000 revised HIV surveillance case definition
incorporates positive test results or reports of a
detectable quantity of HIV nucleic acid or plasma
HIV RNA.
The pediatric case definition incorporates the
revised 1994 pediatric classification system for
evidence of HIV infection. Cases among children
with their first positive results by Western blot or HIV
detection tests before October 1994 were categorized
according to the 1987 classification system. For
children of any age with an AIDS-defining condition
that requires evidence of HIV infection, a single
positive HIV virologic test result (i.e., HIV nucleic
acid [DNA or RNA], HIV viral culture, HIV p24
antigen) is sufficient for a reportable AIDS diagnosis
if the diagnosis is documented by a physician.
Although completeness of reporting of AIDS
cases to state and local health departments differs by
geographic region and patient population, studies
conducted by state and local health departments
indicate that the reporting of AIDS cases in most
areas of the United States is more than 85% complete [10–13]. In addition, multiple routes of exposure, opportunistic infections diagnosed after the initial
AIDS case report was submitted to CDC, and vital
status may not be determined or reported for all
cases. However, for persons reported as having
AIDS, the reporting of deaths is estimated to be more
than 90% complete [14]. (See Commentary for
discussion of duplicates.)
Since January 1, 1994, CDC has not accepted
AIDS case reports that meet only the laboratorybased immunologic criteria of the 1993 expanded
surveillance case definition [7] if information on sex
or race/ethnicity was missing. A small number of
cases previously reported to CDC without those
variables have been returned to the health departments for follow-up and have been deleted from
the totals.
Tabulation and Presentation of Data
Data in this report are provisional. This report
includes information received by CDC through June
30, 2005. For analyses of cases of HIV infection, we
used data from 35 areas (i.e., 33 states, Guam and
the U.S. Virgin Islands) that have had HIV infection
reporting for a sufficient time (i.e., at least since
2000) to allow for stabilization of data collection and
for adjustment of the data in order to monitor trends.
Reports of cases of AIDS,
Technical
HIVNotes
infection, and HIV/AIDS
This report is organized in 5 sections. In Sections
1–3 (i.e., Tables 1–12, Figure 1, and Maps 1 and 2),
data have been statistically adjusted to correct
for delays in the reporting of cases and deaths;
unreported risk factors have been statistically redistributed to better present the trends in the epidemic
and the distribution of risk characteristics among
affected populations. To assess trends in cases,
deaths, or prevalence, it is preferable to use adjusted
data, presented by year of diagnosis instead of year
of report. Section 4, which presents survival data, is
discussed later in the Technical Notes. In Section 5
(Tables 14–23), HIV and AIDS data are tabulated by
date of report to CDC. Data for the U.S. dependencies, possessions, and associated nations are included
in the table totals unless their exclusion is specified in
a footnote. The U.S. dependencies, possessions, and
associated nations comprise Puerto Rico, the U.S.
Virgin Islands, Guam, American Samoa, and the
Commonwealth of the Northern Mariana Islands. The
last 2 areas constitute the category of Pacific Islands,
U.S., as listed in this report.
Selection of areas with mature HIV reporting
systems for analysis of cases of HIV/AIDS and
HIV infection (not AIDS)
The inclusion of areas with mature (i.e. since at
least 2000) confidential name-based HIV reporting
for tabulation and presentation of HIV/AIDS and
HIV infection (not AIDS) data was based on the date
of the implementation of HIV reporting in the area
and the ability to calculate 4 years of reporting delays
in order to display trends reliably. For this report, 35
areas with laws or regulations requiring confidential
name-based HIV infection reporting since 2000 were
eligible for inclusion. The 35 areas are Alabama,
Alaska, Arizona, Arkansas, Colorado, Florida, Idaho,
Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey,
New Mexico, New York, Nevada, North Carolina,
North Dakota, Ohio, Oklahoma, South Carolina, South
Dakota, Tennessee, Texas, Utah, Virginia, West
Virginia, Wisconsin, Wyoming, Guam, and the U.S.
Virgin Islands.
Selection of areas for analyses of reports of
HIV infection (not AIDS)
Areas included in tabulations for reports of HIV
infection (not AIDS) are based on the date of imple-
mentation of name-based HIV infection reporting
before the end of 2004. For Tables 16, 18, 20, and 22,
we used data from 42 areas to describe reports of
cases of HIV infection (not AIDS).
Age groups
For Tables 8–12 and Maps 1 and 2, age groups of
persons living with HIV/AIDS, HIV infection (not
AIDS), or AIDS are based on the person’s age as of
December 31, 2004. For Table 7, age groups of
persons who died with AIDS are based on the
person’s age at the time of death. For all other tables,
age groups are based on the person’s age at the first
documented positive HIV-antibody test result for
persons with a diagnosis of HIV infection (not AIDS),
and age at diagnosis of AIDS for persons with a
diagnosis of AIDS. The age category for adults and
adolescents comprises persons age 13 years and
older; the age category for children comprises
children younger than 13 years of age.
Race and ethnicity
In the Federal Register for October 30, 1997
[15], the Office of Management and Budget
announced the Standards for Maintaining, Collecting,
and Presenting Federal Data on Race and Ethnicity,
also known as Statistical Policy Directive 15. These
standards, which superseded the 1977 standards,
reflected a change in federal policy regarding the
collection of race and ethnicity data; implementation
by January 1, 2003 was mandated. At a minimum,
data on the following race categories should be
collected:
• American Indian or Alaska Native
• Asian
• black or African American
• Native Hawaiian or Other Pacific Islander
• white
Additionally, systems must be able to retain information when multiple racial categories are reported.
Two ethnicity categories should be collected
regardless of race:
• Hispanic
• not Hispanic.
Because data for this document were compiled
from reports to CDC through June 2005, race and
ethnicity information were collected under 2 systems.
The race and ethnicity categories in the system used
through December 2002 are maintained in this
Technical Notes
Reports of cases of AIDS, HIV infection, and HIV/AIDS
41
document because most case reports were submitted
under that system. Persons who reported multiple
racial categories or whose race was unknown are
included in the total numbers in Tables 1–5, 7–11,
13, and 19–23. Also, persons reported as nonHispanic may include persons whose ethnicity was
not reported.
•
Tabulation of cases of HIV/AIDS and AIDS
•
In this report, the term HIV/AIDS is used to refer
to 3 categories of cases: (1) new diagnoses of HIV
infection (not AIDS), (2) new diagnoses of HIV
infection with later diagnoses of AIDS, and (3)
concurrent diagnoses of HIV infection and AIDS.
For analyses of HIV/AIDS data, we used data from
35 areas (i.e., 33 states, Guam, and the U.S. Virgin
Islands) that have had HIV infection reporting for a
sufficient length of time (i.e., at least since 2000) to
allow for stabilization of data collection and for
adjustment of the data in order to monitor trends.
Tables 1, 2, 8, and 9 summarize cases and prevalence
of HIV/AIDS. For analysis of AIDS cases, we used
data from the 50 states, the District of Columbia, U.S.
territories and other associated nations.
Tabulation of persons living with HIV/AIDS,
HIV infection (not AIDS), and AIDS
Tabulation of persons living with HIV/AIDS,
HIV infection (not AIDS), or with AIDS (Tables 8–
12 and Maps 1 and 2) are not actual counts of cases
reported to the surveillance system. The estimates
are based on reported cases which have been
adjusted for delays in reporting of cases and deaths.
Tabulation of deaths of persons with AIDS
Tabulation of deaths of persons with AIDS
(Table 7) are not actual counts of deaths reported to
the surveillance system. The estimates are based on
reported deaths which have been adjusted for delays
in reporting.
Geographic designations
Regions of residence included in the report are
defined as follows.
• Northeast: Connecticut, Maine, Massachusetts,
New Hampshire, New Jersey, New York,
Pennsylvania, Rhode Island, and Vermont
• Midwest: Illinois, Indiana, Iowa, Kansas,
Michigan, Minnesota, Missouri, Nebraska, North
Dakota, Ohio, South Dakota, and Wisconsin
42
•
South: Alabama, Arkansas, Delaware, District of
Columbia, Florida, Georgia, Kentucky, Louisiana,
Maryland, Mississippi, North Carolina, Oklahoma,
South Carolina, Tennessee, Texas, Virginia, and
West Virginia
West: Alaska, Arizona, California, Colorado,
Hawaii, Idaho, Montana, Nevada, New Mexico,
Oregon, Utah, Washington, and Wyoming
U.S. dependencies, possessions, and associated nations: Guam, Puerto Rico, the U.S.
Pacific Islands, and the U.S. Virgin Islands.
Metropolitan Statistical Areas
In the Federal Register for December 27, 2000,
the Office of Management and Budget (OMB)
published revised standards for defining metropolitan
statistical areas (MSA) for use in federal statistical
activities [16]. These standards provided for the
identification of MSAs in the United States and
Puerto Rico and replaced and superseded the 1990
standards. The adoption of the new standards was
effective as of December 27, 2000. The OMB
announced new MSA definitions based on the new
standards and Census 2000 data on June 6, 2003 [17].
Table 15 presents reported AIDS cases, by MSA,
for areas with population ≥ 500,000. MSAs for
Table 15 are defined by the OMB according to their
most recent update of statistical areas in November
2004 [18].
Survival analyses
For the survival analyses presented in Section 4,
Table 13 and Figures 2–4, we used time analysis
methods for calculating survival versus death for
AIDS case data reported through June 30, 2004.
Table 13 was limited to AIDS cases diagnosed in
2000, and Figures 2–4 were limited to cases diagnosed during 1996–2003. Table 13 and the figures
were limited to deaths through December 2004; this
was done to allow at least 6 months for a death to be
reported by June 30, 2005, and to allow at least 1
month after AIDS diagnosis.
Transmission Categories
Transmission category is the term for the
classification of cases that summarizes a person’s
possible HIV transmission risk factors; the summary
classification results from selecting, from the presumed hierarchical order of probability, the one risk
factor most likely to have been responsible for
Reports of cases of AIDS,
Technical
HIVNotes
infection, and HIV/AIDS
transmission. For surveillance purposes, cases of
HIV/AIDS, HIV infection (not AIDS), and AIDS are
counted only once in the hierarchy of transmission
categories. Persons with more than one reported risk
factor for HIV are classified in the transmission
category listed first in the hierarchy. The exception is
men who report sexual contact with other men and
injection drug use; this group makes up a separate
transmission category.
Persons whose transmission category is classified
as male-to-male sexual contact include men who
report sexual contact with other men (i.e., homosexual contact) and men who report sexual contact
with both men and women (i.e., bisexual contact).
Persons whose transmission category is classified
as heterosexual contact are persons who report
specific heterosexual contact with a person with, or
at increased risk for, HIV infection (e.g., an injection
drug user).
Adults and adolescents born in, or who had sex
with someone born in, a country where heterosexual
transmission was believed to be the predominant
mode of HIV transmission (formerly classified as
Pattern II countries by the World Health Organization) are no longer classified as having heterosexually
acquired HIV infection unless they meet the criteria
stated in the preceding paragraph. Similar to other
cases in persons who were reported without information about a behavioral or a transfusion risk factor for
HIV infection, these cases are classified (in the
absence of other risk factor information that would
classify them in another transmission category) as “no
risk factor reported or identified” [19]. Cases in
children whose mother was born in, or whose mother
had sex with someone born in, Pattern II countries
are now classified (in the absence of other risk factor
information that would classify them in another
transmission category) as “Mother with documented
HIV infection, a risk factor for HIV infection, or HIV
infection without a specified risk factor.”
Cases in persons with no reported exposure to
HIV through any of the routes listed in the hierarchy
of transmission categories are classified as “no risk
reported or identified.” No identified risk factor
(NIR) cases include cases that have been followed
up by local health department officials; cases in
persons whose exposure history is missing because
they died, declined to be interviewed, or were lost to
follow-up; and cases in persons who were interviewed or for whom other follow-up information
was available and no mode of exposure was identi-
fied. As of September 2000, the procedures for
investigating cases reported without risk factor
information changed from ascertaining a risk factor
for all reported cases to estimating risk factor distributions from statistical models and population-based
samples. States continue to investigate any report of
an unusual exposure to HIV and report these cases
to CDC. CDC will continue to tabulate the number
of documented unusual exposures to HIV reported
by the states.
Because recently reported cases of HIV infection or AIDS are more likely to be reported without
sufficient risk factor information, recent AIDS
incidence in some transmission categories will be
underestimated unless an adjustment is made. For
tables and figures showing the estimated cases of
HIV infection (not AIDS) and AIDS, the adjustment
of cases without risk factor information among adults
and adolescents is based on the redistributions of
transmission category, by specific sex, race, and
region, of cases that were diagnosed 3 to 10 years
prior and initially assigned to the “no identified risk
factor” category but that were later reclassified.
Similar adjustments of such cases among children
are based on transmission-category redistribution
of all cases diagnosed during that period and later
reclassified [20, 21].
Reporting Delays
Reporting delays (time between diagnosis of
HIV infection or AIDS and report to CDC) may
differ among exposure, geographic, racial/ethnic,
age, sex, and vital status categories; for some AIDS
cases, delays have been as long as several years.
Adjustments of the estimated data on HIV infection
(not AIDS) and on AIDS to account for reporting
delays are calculated by a maximum likelihood
statistical procedure. This procedure not only takes
into account the differences in reporting delays
among exposure, geographic, racial/ethnic, age, sex,
and vital status categories, it is based on the assumption that reporting delays in these categories have not
changed over time [22, 23].
Rates
Rates per 100,000 population were calculated for
the numbers of AIDS cases in 2004, as well as for
persons living with HIV infection (not AIDS) at
the end of 2004. Population denominators used to
compute these rates for the 50 states and the District
Reports of cases of AIDS,
Technical
HIV infection,
Notes and HIV/AIDS
43
of Columbia were based on official postcensus
estimates for 2004 from the U.S. Census Bureau [24]
and bridged-race estimates for 2003 obtained from
the National Center for Health Statistics [25]. The
bridged estimates are based on the Census 2000
counts and produced under a collaborative agreement
with the U.S Census Bureau. These estimates result
from bridging the 31 race categories used in Census
2000, as specified in the 1997 Office of Management
and Budget standards [15] for the classification of
data on race and ethnicity, to the 4 race categories
specified in the 1977 standards. Population denominators for U.S. dependencies, possessions, and
associated nations were based on official postcensus
estimates and Census 2000 counts from the U.S.
Census Bureau’s International Database. Each rate is
calculated by dividing the number of cases reported
during the 12 months in 2004 (or the number of
persons living with HIV infection or with AIDS at the
end of 2004) by the 2004 population, multiplied by
100,000. The denominators used for computing age-,
sex-, and race-specific rates are computed by
applying the age, sex, and race proportions from the
bridged-race population estimates for 2000 to the
2004 postcensus estimates of the total population for
each state. When bridged-race population denominators for the U.S. dependencies, possessions, and
associated nations were not available, proportions
from the U.S. Census Bureau’s International Database for 2000 were used to estimate the age- and
sex-specific subpopulations [26].
References
1. CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection
and acquired immunodeficiency syndrome.
MMWR 1999;48(No. RR-13):29-31.
2. CDC. Guidelines for the use of antiretroviral
agents in pediatric HIV infection. MMWR
1998;47(No. RR-4):1-43.
3. CDC. Current trends: classification system for
human immunodeficiency virus (HIV) infection in
children under 13 years of age. MMWR 1987;
36:225-230, 235.
44
4. CDC. Diagnosis and reporting of HIV and AIDS
in states with integrated HIV and AIDS surveillance—United States, January 1994–June 1997.
MMWR 1998; 47:309-314.
5. CDC. Current trends: revision of the case
definition of acquired immunodeficiency syndrome for national reporting—United States.
MMWR 1985; 34:373-375.
6. CDC. Revision of the CDC surveillance case
definition for acquired immunodeficiency syndrome. MMWR 1987;36(No. SS-1):1S-15S.
7. CDC. 1993 Revised classification system for
HIV infection and expanded surveillance case
definition for AIDS among adolescents and
adults. MMWR 1992;41(No. RR-17):1-19.
8. CDC. Current trends update: acquired immunodeficiency syndrome—United States, 1994.
MMWR 1995; 44:64-67.
9. CDC. 1994 Revised classification system for
human immunodeficiency virus infection in
children less than 13 years of age; official
authorized addenda: human immunodeficiency
virus infection codes and official guidelines for
coding and reporting ICD-9-CM. MMWR
1994;43(No. RR-12):1-19.
10. Buehler JW, Berkelman RL, Stehr-Green JK.
The completeness of AIDS surveillance. J
Acquire Immune Defic Syndr 1992;5:257-264.
11. Rosenblum L, Buehler JW, Morgan MW, et al.
The completeness of AIDS case reporting, 1988:
a multisite collaborative surveillance project. Am J
Public Health 1992;82:1495-1499.
12. Schwarcz SK, Hsu LC, Parisi MK, Katz MH.
The impact of the 1993 AIDS case definition on
the completeness and timeliness of AIDS surveillance. AIDS 1999;13:1109-1114.
Reports of cases of AIDS,
Technical
HIVNotes
infection, and HIV/AIDS
13. Klevens RM, Fleming PL, Li J. The completeness, validity, and timeliness of AIDS surveillance
data. Ann Epidemiol 2001;11:443-449.
20. Green TA, Karon JM, Nwanyanwu OC. Changes
in AIDS incidence trends in the United States. J
Acquir Immune Defic Syndr 1992;5:547-555.
14. Karon JM, Rosenberg PS, McQuillan G, Khare
M, Gwinn M, Petersen LR. Prevalence of HIV
infection in the United States, 1984 to 1992.
JAMA 1996;276:126-131.
21. Neal JJ, Fleming, PL, Green TA, Ward JW.
Trends in heterosexually acquired AIDS in the
United States, 1988 through 1995. J Acquire
Immune Defic Syndr Hum Retrovirol
1997;14:465-474.
15. National Archives and Records Administration.
Revisions to the standards for the classification of
federal data on race and ethnicity. Federal
Register 1997;62:58781-58790. Available at:
http://www.whitehouse.gov/omb/fedreg/
ombdir15.html.
16. National Archives and Records Administration.
Standards for defining metropolitan and
micropolitan statistical areas. Federal Register
2000;65:82228-82238. Available at: http://
www.whitehouse.gov/omb/fedreg/
metroareas122700.pdf.
17. Office of Management and Budget. Revised
Definitions of metropolitan statistical areas, new
definitions of micropolitan statistical areas and
combined statistical areas, and guidance on uses
of the statistical definitions of these areas. OMB
Bulletin 03-04. Available at: http://
www.whitehouse.gov/omb/bulletins/b03-04.html.
18. Office of Management and Budget. Update of
statistical area definitions and guidance on their
uses. OMB Bulletin 05-02. Available at: http://
www.whitehouse.gov/omb/bulletins/fy05/b0502.html.
22. Green TA. Using surveillance data to monitor
trends in the AIDS epidemic. Stat Med
1998;17:143-154.
23. Karon JM, Devine OJ, Morgan WM. Predicting
AIDS incidence by extrapolating from recent
trends. In: Castillo-Chavez C, ed. Mathematical
and Statistical Approaches to AIDS Epidemiology. Berlin: Springer-Verlag; 1989;83:58-88.Lecture Notes in Biomathematics.
24. U.S. Census Bureau. Population estimates: entire
data set. Available at: http://www.census.gov/
popest/datasets.html. Accessed September 1,
2005.
25. National Center for Health Statistics. Datasets
available at: ftp://ftp.cdc.gov/pub/
Health_Statistics/NCHS/datasets/nvss/bridgepop/
pcen_v2003.txt. Accessed September 1, 2005.
26. U.S. Census Bureau. Census 2000: the island
areas. Available at: http://www.census.gov/
population/www/cen2000/islandareas.html.
Accessed September 1, 2005.
19. CDC. Current trends: heterosexually acquired
AIDS—United States, 1993. MMWR 1994;
43:155-160.
Reports of cases of AIDS,
Technical
HIV infection,
Notes and HIV/AIDS
45
Web addresses for state or local HIV and AIDS surveillance reports
State or Area
URL for state or local HIV and AIDS surveillance report
Alabama
Alaska
Arizona
Arkansas
California
Chicago
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Houston
Idaho
http://www.adph.org/AIDS/default.asp?TemplateNbr=3&DeptID=96&TemplateId=3575
http://www.epi.hss.state.ak.us/bulletins/docs/b2005_13.pdf
http://www.azdhs.gov/phs/hiv/hiv_epi.htm
http://www.healthyarkansas.com/stats/hiv_aids/033105_report.pdf
http://www.dhs.ca.gov/AIDS/Statistics/default.htm
http://egov.cityofchicago.org/webportal/COCWebPortal/COC_EDITORIAL/AIDSChicago04.pdf
http://www.cdphe.state.co.us/dc/HIVSTDPROGS.ASP
http://www.dph.state.ct.us/BCH/infectiousdise/2003/final%20pages/aids_surv_home_Z.htm
http://www.dhss.delaware.gov/dhss/dph/epi/disstatshiv.html
http://doh.dc.gov/doh/cwp/view,A,1371,Q,598650,dohNav_GID,1802,dohNav,|33200|34259|,.asp
http://www.doh.state.fl.us/Disease_ctrl/aids/trends/trends.html
http://health.state.ga.us/programs/stdhiv/index.asp
http://www.state.hi.us/health/healthy-lifestyles/std-aids/aboutus/prg-aids/aids_rep/index.html
http://www.houstontx.gov/health/HIV-STD/QRT2004.pdf
http://www.healthandwelfare.idaho.gov/Portals/_Rainbow/Documents/health/51eacf4d-fb4c-412d9033-74dc0ffd8f32.pdf
http://www.idph.state.il.us/aids/stats.htm
http://www.in.gov/isdh/programs/hivstd/quarterly/quarterly.htm
http://www.idph.state.ia.us/adper/hiv_aids_programs.asp#surveillance
http://www.kdhe.state.ks.us/hiv-std/surveillance.html
http://chfs.ky.gov/NR/rdonlyres/E8B9DE2B-71E6-4BA3-B50D-F4DBCF61D43B/0/June2004Semiannual
ReportPublisher2000.pdf
http://lapublichealth.org/phcommon/public/reports/rptspubdisplay.cfm?unit=hiv&ou=ph&prog=hae
http://www.oph.dhh.state.la.us/HIVAIDS/surveillance/reports.html
http://www.maine.gov/dhhs/boh/ddc/data_statistics_surveillance.htm
http://www.dhmh.state.md.us/health/info&data.htm
http://www.state.ma.us/dph/cdc/aids/aidsprog.htm
http://www.michigan.gov/mdch/0,1607,7-132-2944_5320-36307—,00.html
http://www.health.state.mn.us/divs/idepc/diseases/hiv/hivstatistics.html
http://www.msdh.state.ms.us/msdhsite/index.cfm/14,1185,150,html#Mississippi
http://www.dhss.state.mo.us/HIV_STD_AIDS/Data.html
http://www.dphhs.mt.gov/PHSD/STD-HIV/MTComprehensviePlan2005-2007.doc
http://www.hhs.state.ne.us/dpc/HIV.htm
http://health2k.state.nv.us/hiv/survey/special.htm
http://www.dhhs.nh.gov/DHHS/CDCS/LIBRARY/Data-Statistical+Report/hiv-aids-report.htm
www.state.nj.us/health/aids/aidsqtr.htm
http://www.aidsinfonet.org/nmepi2003/index.php
http://www.health.state.ny.us/diseases/aids/statistics/index.htm
http://www.nyc.gov/html/doh/html/dires/hivepi.shtml
http://www.epi.state.nc.us/epi/hiv/surveillance.html
http://www.ndhiv.com/programs/mediafiles/HIVAIDSEpidemiologicReport2004.pdf
http://www2.odh.ohio.gov/Data/Inf_Dis/hivcov.htm
www.health.state.ok.us/program/hivstd/epi/stats.htm
http://oregon.gov/DHS/ph/hst/index.shtml
http://www.health.state.pa.us/hiv-epi/extranet1.1/index.htm
www.phila.gov/health/units/aaco/aidsphila.html
http://www.health.ri.gov/hiv/data.php
www.dph.sf.ca.us/php/aidssurvunit.htm
http://www.dhec.sc.gov/health/disease/stdhiv/surveillance.htm
http://www.state.sd.us/doh/Disease/stats.htm
http://www.coetenn.com/IndexTNHIVdata.htm
www.tdh.state.tx.us/hivstd/stats/default.htm
http://health.utah.gov/cdc/hivsurveillance/sp.htm
http://www.healthyvermonters.info/hs/epi/cdepi/AIDS/aidshome.shtml
http://www.vdh.state.va.us/std/datahome2.asp
www.metrokc.gov/health/apu/epi/epistats.htm
http://www.wvdhhr.org/bph/oehp/sdc/aids.htm#Surveillance
http://www.dhfs.state.wi.us/aids-hiv/Stats/AIDS_HIV_StatsRprts_Index.htm
http://wdhfs.state.wy.us/hiv
Illinois
Indiana
Iowa
Kansas
Kentucky
Los Angeles
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Philadelphia
Rhode Island
San Francisco
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Note. Local HIV and AIDS surveilance reports were not available electronically for the following areas: American Samoa, Federation of
Micronesia, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands, U.S.
46
Web addresses
Reports of
forcases
state of
or AIDS,
local HIV
HIVand
infection,
AIDS Surveillance
and HIV/AIDS
Reports
| File Type | application/pdf |
| File Title | Microsoft Word - Document4 |
| Author | pas3 |
| File Modified | 2006-11-02 |
| File Created | 2006-11-01 |